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Walters Aji Tebung, PhD 
Concordia University, 2016 
 The prediction of protein function based on the role of orthologous proteins in other 
species is a common practice in life sciences. While such predictions prove accurate in some 
cases, a growing number of structurally orthologous proteins with different roles have been 
reported. Functional differences among structurally orthologous transcription factors create what 
has been termed transcriptional rewiring. We have characterized some zinc cluster transcription 
factors (ZCFs) in Candida albicans (C. albicans) including Ppr1, Stb5 and Put3. We identified 
cases of total rewiring, partial rewiring and functional conservation (no rewiring) but with some 
regulatory fine-tuning between C. albicans and S. cerevisiae for the ZCFs Ppr1, Stb5 and Put3 
respectively.  
 We show that Ppr1 regulates purine catabolism in C. albicans, which is different from its 
role in S. cerevisiae where it regulates pyrimidine biosynthesis. We identified that Ppr1 rewired 
at Naumovozyma castellii in the phylogeny, and propose that Ppr1 rewiring is a result of cellular 
adaptations to permit growth in hypoxic conditions. In another study, we report that Stb5 has 
gone from regulating drug efflux pumps and glyoxylate cycle enzymes in C. albicans, to only 
regulating drug efflux pumps in S. cerevisiae. The glyoxylate cycle is required for C. albicans 
virulence, and our stb5 null mutants showed sensitivity to the echinocandin class of antifungal 
drugs. We therefore propose Stb5 as a potential drug target against candidiasis. Finally, we 
discovered that Put3 has conserved its role in regulating proline catabolism between C. albicans 
and S. cerevisiae. However, unlike the case of S. cerevisiae where Put3 can only activate 
transcription of proline catabolism genes in the absence of rich nitrogen sources, there is no 
equivalent restriction in C. albicans where Put3 preserves its ability to activate proline 
degradation even in the presence of the rich nitrogen source ammonium sulfate, thus allowing for 
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the use of proline as a carbon source. The robust ability of C. albicans to obtain nutrients from a 
variety of sources adds to its efficiency as a pathogen. 
 These studies correlate transcriptional rewiring to species requirements, where different 
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Chapter 1: General introduction 
1.1 Zinc cluster transcription factors 
 Transcription factors (TFs) bind to specific DNA sequences at gene promoters to either 
activate or repress transcription. Transcription factors have been grouped into families such as the 
basic helix loop helix (bHLH) class [1], the zinc finger TFs [2], the homeo box family [3], and 
the leucine zipper TFs family [4]. There are 55 zinc cluster transcription factors (ZCFs) in 
Saccharomyces cerevisiae (S. cerevisiae) and 82 ZCFs in Candida albicans (C. albicans), which 
makes this class of transcription factors one of the largest in both fungi. ZCFs make up 
approximately one third of transcription factors in C. albicans and are known to play a role in the 
regulation of diverse processes such as metabolism, meiosis, virulence, and antifungal drug 
resistance [5-7]. All ZCFs possess the conserved sequence CX2CX6CX5–12CX2CX6–8C in their 
DNA-binding domain and usually possess a lysine residue (sometimes replaced by arginine, 
histidine, or glutamine) between the second and third cysteines that directly interacts with the 
conserved cytosine and guanine bases through hydrogen bonding [8] (Figure 1.1) during DNA 
binding (Figure 1.1). ZCFs predominantly bind DNA as homodimers using their N-terminal zinc 
finger motifs to hydrogen bond with CGG nucleotide triplets that are oriented in everted, 
inverted, or direct repeats [7,8] (Figure 1.2). The binding specificity is based on the spacing of 
the CGG sequences, which is controlled by the length and folding of a non-conserved linker 
sequence [7,9-11] (Figure 1.3). The conserved cysteines complex two zinc ions that are important 
in facilitating the DNA binding of the protein [12,13].  
 The ZCF Gal4 is a classic model for zinc cluster protein function. Gal4 binds to a typical 
zinc cluster transcription factor binding site, 5'-CGG(N11 )CCG-3', at the promoters of C. 
albicans glucose catabolism and subtelomeric TLO genes [14-17] and S. cerevisiae galactose 
catabolism genes or GAL genes (GAL1, GAL2, GAL3, GAL7, GAL10, and GAL80) [18,19] to 
transcriptionally regulate these processes. S. cerevisiae Gal80 on the other hand represses GAL 
genes by binding the transcriptional activation domain of Gal4 to inhibit the transcription factor 
from transcriptionally activating GAL genes [15]. To relieve Gal4 inhibition in S. cerevisiae, 
Gal3 sequesters Gal80 in the cytoplasm, in the presence of galactose and ATP, and forms a 
complex with Gal80 that prevents it from inhibiting Gal4 and thus allowing the activation of 
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GAL gene expression [15]. Another interesting but unexplained observation is the clustering of 
the Gal4 target genes, GAL1, GAL7, and GAL10, in S. cerevisiae (near the centromere of S. 
cerevisiae chromosome 2) and its close relatives [15]. 
 
 
Figure 1.1: Residues of the S. cerevisiae zinc cluster transcription factor Ppr1 interacting with DNA during 
binding. Hydrogen bonding is indicated by arrows and Van Der Waals interactions are indicated by broken lines. 






Figure 1.2: The different ways zinc cluster transcription factors bind CGG sequences [7] 
 
 Understanding ZCFs and any differences in their roles between C. albicans and S. 
cerevisiae could reveal the reason why C. albicans is a human pathogen but S. cerevisiae is not, 
and could help improve the treatment of candidiasis and fight drug resistance.  
A model for zinc cluster protein DNA recognition. 





Figure 1.3: DNA binding sequences of some zinc cluster transcription factors. The number of spacer bases helps 
to determine specificity [7,20] 
 
1.2 Transcriptional rewiring 
 Different ascomycetes are known to use orthologous transcription factors to regulate 
varying metabolic circuits [17,21], a process that has been termed transcriptional rewiring [22]. 
As evident by the growing reports on transcriptional rewiring events, defining the match between 
transcription factors and metabolic pathways based solely on structural similarity of the 
transcription factors is not reliable. While the function of orthologous transcription factors remain 
a good starting point when predicting the role of newly identified orthologs in related species, 
further investigation is often required to establish cellular processes regulated by newly identified 
othologous transcription factors. 
 In addition to being a classically studied TF, Gal4 provides a clear example of this 
phenomenon of transcriptional rewiring. The C. albicans Gal4 protein regulates glucose 
catabolism [16], while the S. cerevisiae Gal4 protein regulates galactose catabolism [14,15] . 
Although Gal4 controls different circuits in the two species, the DNA binding motif used by the 
TF to regulate the respective pathways in the species remains the same. Other rewired 
transcription factors that use similar motifs to carry out different functions in different species 
Gal4 (11 spacer bases)
Ppr1 
(6 spacer bases)
STB4 (1 spacer base) STB5
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include Cbf1 [23] and Ppr1(Chapter 2 of this thesis). In the absence of large scale comparative 
location binding studies, we are essentially limited to identifying rewiring events by 
bioinformatical motif searches, which would miss examples where the actual binding motif of the 
TF has rewired. Table 1.1 shows clear examples of othologous transcription factors regulating 
related sets of genes in C. albicans and S. cerevisiae, but identifies several examples where 
orthologous transcription factors play different roles in the two species. Table 1.1 was created by 
taking some S. cerevisiae TFs that regulate an obvious pathway or process and have a clear 
binding motif, and looking in C. albicans for this same motif at the promoters of the orthologs of 
the select targets identified in yeast. Top computationally identified targets were included, as well 
as experimentally determined targets. Note however that transcription factor functions presented 
in Table 1.1 are based specifically on the presence or absence of the S. cerevisiae transcription 
factor motif at promoters of C. albicans genes and usually require further studies to establish the 
functions predicted. Table 1.1 suggests that Adr1, for example, regulates the same set of genes in 
S. cerevisiae and C. albicans. The C. albicans ADR1 mutant phenotype, however, suggests a 
different set of target genes [24-26] compared to targets of the S. cerevisiae ortholog; more 
experimental evidence is therefore required to establish the actual C. albicans Adr1 binding sites 
and regulatory role. On the other hand, the table rightfully predicts that Ppr1 is rewired between 
S. cerevisiae and C. albicans; this Ppr1 rewiring prediction has been experimentally confirmed 
and presented in Chapter 2 of this thesis. Leu3 and Rpn4 are predicted in Table 1.1 to play the 
same role in C. albicans and S. cerevisiae, but there is currently no experimental evidence of this 
functional conservation; it will be important to acquire experimental evidence in support of the in 
silico predictions. A special case is that of Put3 where the DNA binding motif, as identified in S. 
cerevisiae, is not present upstream of the proline degradation genes in C. albicans as shown in 
Table 1.1 and our ChIP-Chip data. One would assume that the transcription factor has been 
rewired, but our data suggest that Put3 does bind at least one of the two key enzymes of the 
proline degradation pathway and regulates proline catabolism in C. albicans through 
transcriptional regulation of Put1 and Put2 as reported in Chapter 4 of this thesis. It is not 
common for a transcription factor to use different DNA binding motifs to regulate the same set of 
genes in different species, yet not impossible since indirect conservation by creation of one 
binding site and destruction of another has been shown to result in transcription factors regulating 
the same genes in different species but using different binding sites [27]. Studies have shown that 
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the transcription factors CEBPA (CCAAT/enhancer-binding protein alpha) and HNF4A 
(hepatocyte nuclear factor 4 alpha) have conserved their functions between multiple species 
including humans, mice, and dogs, but use different species-specific binding sites to carry out the 
same regulatory function in the different species [28]. It would therefore be interesting to identify 
the actual Put3 binding site in C. albicans for comparison with the S. cerevisiae motif. These 
experimental findings suggest that Put3 plays essentially the same role in C. albicans and S. 
cerevisiae.  
 S. cerevisiae and C. albicans are therefore divergent enough to have frequent examples of 
rewiring, but not so divergent that no conserved circuits can be identified. In some rewiring 
events, orthologous transcription factors regulate different metabolic pathways, and in other 
instances, orthologous metabolic pathways are regulated by distinct transcription factors. Gal4 is 
a classical example of a zinc cluster transcription factor that regulates different processes in the 
two related ascomycetes S. cerevisiae and C. albicans. Gal4 and Tye7 have been identified as the 
regulators of glucose metabolism in C. albicans [16], but Gal4 has been rewired to control 
galactose catabolism in S. cerevisiae [14,15], meanwhile Tye7 remains linked to glucose 
metabolism in both species [16]. In the other hand, the Gcr1 and Gcr2 proteins transcriptionally 
control glycolytic enzyme expression to regulate glucose metabolism in S. cerevisiae [29], but are 
not present in C. albicans. Differences in ribosomal protein gene expression observed between C. 
albicans and S. cerevisiae highlight just how flexible metabolic pathways can get through 
evolution. Tbf1 is the chief regulator of ribosomal protein gene expression in C. albicans, a 
process that is centrally regulated by Rap1 in S. cerevisiae [30-32]. This rewiring event is not 
some strategy to cover for a missing Tbf1 since Tbf1, Rap1, as well as the adapter proteins, Ifh1 
and Fhl1, are all present in both species. The connectivity to the ribosomal protein is however 
rearranged such that different DNA binding proteins are used by C. albicans and S. cerevisiae to 









Table 1.1 Transcriptional regulatory network rewiring or conservation among orthologous transcription 
factors 
We identified some S. cerevisiae TFs that regulate an obvious pathway or process and have a clear binding motif, 
and then looked for the motif at the promoters of the C. albicans orthologs of some of the target genes. Some top 
computationally identified target genes were used for the analysis, as well as experimentally determined targets. If a 
motif is over-represented in target genes compared to the control, the P value will be highly significant. Motif over-
representation was analyzed using ‘compare motif analysis’ option based on hypergeometric test (significance 
threshold 0.05) followed by Bonferroni correction as implemented in the MotifLab software package [62]. Motifs 
showing significant and non-significant (NS) P values are based on over-representation analysis in 400 bp promoter 
regions of the select genes that are directly regulated by each transcription factor in S. cerevisiae, or C. albicans 




S. cerevisiae  C. albicans  
ADR1  8.30E-03  4.70E-02 
ARO80 1.18E-07  NS 
CUP2 6.60E-04  NS 
GAL4 5.82E-09 NS 
LEU3 4.39E-09  3.00E-05 
PPR1 9.10E-04  NS 
PUT3 5.92E-07  NS  
RPN4 6.19E-18  1.70E-10 
 
Through bioinformatic analyses of ascomycete fungi, it was shown that the Tbf1 target motif 
dominates the promoters of the RP genes in C. albicans and its relatives, and the Rap1 motif 
dominates in S. cerevisiae and its relatives (Figure 1.4A) [21]. The same bioinformatics analyses 
for the motifs using relaxed stringency however showed that many species across the entire 
phylogeny have the potential to adapt their ribosomal protein gene promoters for either Tbf1 or 




Figure 1.4. Transition of Tbf1-Rap1 DNA binding motif across ascomycetes fungi.  
(A) Strict motif scanning (90% threshold) showed dominance of the Rap1 motif in S. cerevisiae and its close 
relatives, whereas Tbf1 dominates in C. albicans and its close relatives. (B) Relaxed stringency (80% threshold) for 
motif scanning showed most species had potential motifs for either Tbf1 or Rap1. Motif scanning was performed 
using software package MotifLab [62]. Species names: A. gos, A. gossypii; C. alb, C. albicans; C. dub, C. 
dubliniensis; C. gla, C. glabrata; C. tro, C. tropicalis; C. par, C. parapsilosis; D. han, D. hansenii; L. elo, L. 
elongisporus; M. gui, M. guilliermondii; K. lac, K. lactis; S. bay, S. bayanus; S. cer, S. cerevisiae; S. par, S. 
paradoxus [21]. 
 
These findings suggest that switching DNA binding transcription factors can be accomplished 
with limited changes at any promoter. What is much more difficult to envision is how these 
changes could be co-ordinated over the multiple promoters of the regulon. Since the overall 
rewiring in S. cerevisiae led to the regulation of highly expressed genes such as the genes for 
glycolytic enzymes as well as those for ribosomal proteins by Rap1, it could be an indicator that 
the coordination of highly expressed genes by Rap1 may set the stage for selective a advantage 
and drive the rewiring from Tbf1 to Rap1 [32]. Other transcriptional rewiring events initially 
identified among ascomycetes involve a sugar metabolic pathway [15], Mcm1 circuitry [33], 
coordination of mitochondrial and cytoplasmic ribosomal protein genes [34], cell type 
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establishment [35], and the cell cycle regulation pathway [36,37]. The rewiring of other cellular 
pathways has also been reported, including iron assimilation [38], sterol biosynthesis [39], and 
mating [35,40].  
Current knowledge of transcriptional rewiring can only partially address questions such as 
how and why transcription factors rewire, and whether or not rewiring is random; for example, 
the fact that the DNA binding sites of Gal4 and Ppr1 moved on from related gene sets to other 
related gene sets could suggest that the rewiring process is not random. Several transcriptional 
rewiring driving forces have so far been reported. A transcription factor originating from 
horizontal gene transfer could hijack a transcriptional regulatory network and force the ancestral 
transcriptional regulator to change functions or end up extinct from the cell [41]. An example of 
such transcription factor rewiring is observed between fungi and animals where the transcription 
factor SBF apparently inserted into the fungi genome from an invading virus, took over the 
transcriptional regulation of the cell cycle from the original transcriptional regulator E2F. E2F 
remains the cell cycle regulator in animals and plants. Evidence shows that both transcription 
factors have the same DNA binding site specificity, which further strengthens this theory [41]. 
The overall structure of the cell cycle regulon has been conserved across species, but many of the 
protein components of the regulon have no orthology with other protein components playing a 
similar role in the cell cycle in other species. In addition to the E2F to SBF transition, Whi5, 
which originates from an unknown source and inhibits SBF in fungi has no homology to the 
animal E2F inhibitor, pRb [41]. Gene duplication is another reported driver of transcriptional 
rewiring because duplicated genes often diverge and evolve to take on new functions [42]. The 
generation of new genes with new functions might require reorganization and/or extension of the 
regulatory network to ensure that the new paralogues are properly expressed and that the 
paralogues do not cross-interfere with each other's specific function [42]. Gene duplication can 
result from whole genome duplication or independent duplication. The rewiring of MalS and 
MalR proteins are a result of gene duplication involving both the transcription factor coding gene 
(MALR) and the target gene, MALS [42]. MALS first duplicated into two paralogous enzymes, 
one that responds to palatinose and is responsible for palatinose utilization, and another that 
responds to maltose and is responsible for maltose utilization. The promiscuous ancestral MALS 
regulator, MalR, can bind both CGC and CGG that are randomly distributed in the un-diverged 
promoters of the homologues of the different genes involved in maltose utilization as well as in 
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palatinose utilization. This promiscuous binding nature allowed MalR to continue, for a while, 
the regulation of both MALS paralogues before eventually duplicating into two specific MALR 
paralogues [42]. One MalR paralogue following a Arg12Cys mutation could no longer bind CGC 
which are selected for in the promoter of maltose specific genes and therefore specialized in 
regulating palatinose utilization. The remaining MalR paralogue evolved to lose the ability to 
activate expression of palatinose-specific genes which are selected to have only one CGG-
containing binding site, while conserving the ability to activate maltose-specific promoters that 
have evolved to contain three CGC binding sites [42]. These findings show how duplication of a 
promiscuous transcription factor and its target genes led to the development of two separate 
regulatory networks [42]. The findings could also suggest that transcription factors with an ability 
to bind multiple regulatory sequences could more easily rewire by specializing in using one of 
their many binding sites to specifically regulate a new process. We also report for Ppr1 in 
Chapter 2 of this thesis how changing the inducer of a transcription factor could drive rewiring. 
 We discuss in this thesis a case of total transcriptional rewiring as well as the likely 
pressures that led to the rewiring event, a case of partial rewiring of a transcriptional regulator, 
and a case where a transcriptional regulator has been preserved but a new regulatory pathway has 
evolved to fine tune its transcriptional role. 
1.3 Relationship between transcriptional rewiring and species lifestyle 
 Transcriptional rewiring is not confined to DNA binding proteins, but has been identified 
among orthologous general transcription factors such as Mediator, SWI/SNF, SAGA, and NuA4. 
This is an indication that transcriptional networks can be rewired both through modifications in 
specific transcription factor regulatory networks and through changes in the subunits and 
connectivities of general transcription regulators [21]. Differences in post-translational 
modifications and protein stability have also been reported among ascomycetes. The pressures 
that drive rewiring and the effects of rewiring on the overall phenotype of species remain less 
well understood. In this thesis, we have attempted to link rewiring to the different lifestyles of the 
pathogen C. albicans and the bread and wine yeast S. cerevisiae. Previous studies had identified 
differences in carbon metabolism between C. albicans and S. cerevisiae that appear to correlate 
with their lifestyles. Such rewiring is observed in the case of glucose metabolism where post-
transcriptional control of protein stability differs significantly between the species. Fungi 
generally shut down expression of the alternative carbon pathway elements and utilize preferred 
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carbon sources such as glucose when presented with options, a process that has been named 
carbon catabolite control or CCC. CCC in S. cerevisiae is through ubiquitin-mediated proteolysis 
where enzymes involved in the use of the alternative carbon source are rapidly degraded in the 
presence of a preferred carbon source such as glucose [43]. In contrast, this proteolysis does not 
occur in C. albicans although the transcriptional regulatory pathway appears to be similar in the 
two fungi, with the repressor Mig1 being the key player in shutting off the transcriptional 
pathways required to breakdown the alternative carbon in both species. For example Icl1 and 
Pkc1 required for oleate utilization in C. albicans persist in the pathogen when the carbon source 
switches from oleate to glucose, even though their gene expression is significantly reduced [44]. 
C. albicans’ enzymes lack the ubiquitination target sites found in the orthologous S. cerevisiae 
proteins, so even though the pathogen has the machinery to degrade the proteins, these specific 
proteins evade this machinery. S. cerevisiae proteins expressed in C. albicans were destabilized 
by the same treatment confirming that C. albicans has the ability to degrade the proteins. These 
differences in protein stability between the two fungi dramatically change the cellular response to 
alternative sugars [45]. Also, C. albicans is quite promiscuous in its sugar use and can grow 
efficiently on a variety of 5-carbon sugars such as xylose [46] and arabinose [47]; sugars that 
normal S. cerevisiae strains are unable to catabolise [48]. Even in the absence of a defined sugar 
source, C. albicans is able to grow using gluconeogenic amino acids to supply carbon for central 
metabolism [49]. S. cerevisiae predominantly uses hexose sugars for energy and growth, while C. 
albicans uses its more advanced carbon metabolism pathways to utilize alternative carbon 
sources, which could improve its chances of survival in diverse host environments such as upon 
phagocytosis by macrophages. C. albicans can switch from glycolysis to the glyoxylate cycle, 
gluconeogenesis, and β-oxidation pathways using key enzymes such as Fbp1, Pck1, and Icl1 that 
allows it to catabolise nonfermentable carbon sources [43,50]. The pathogen also possesses 
additional genes, such as acyl-CoA oxidase, fatty acid-CoA synthase, and oxidoreductases used 
in respiratory catabolism, which might enhance its ability to thrive inside the host [51]. We report 
in this thesis a more liberal use of proline, both as a carbon source and as a nitrogen source by C. 
albicans. Proline is only used as a nitrogen source by S. cerevisiae in the absence of a rich 
nitrogen source such as ammonium sulfate; in contrast our findings establish that C. albicans can 
catabolise proline whether or not ammonium sulfate is present. This could be an indicator that C. 
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albicans is not only flexible in its carbon use but also in its nitrogen use which could further 
favor its pathogenic lifestyle. 
1.4 Thesis aims and organization 
 This study was designed to characterize zinc cluster transcription factors (ZCFs) in C. 
albicans and to identify transcriptional rewiring between orthologous ZCFs in C. albicans and S. 
cerevisiae. There are 55 zinc cluster transcription factors in S. cerevisiae and 82 zinc cluster 
transcription factors in C. albicans making up one third of the overall transcription factors in the 
pathogen. The role that this large class of transcription factors plays in varying cellular processes 
including metabolism, meiosis, virulence, antifungal drug resistance makes ZCFs suitable for 
transcriptional rewiring studies that could in turn reveal the reason why C. albicans is a pathogen 
and S. cerevisiae is not. 
 In Chapter 2, we discuss the total rewiring of the ZCF Ppr1 from purine catabolism in C. 
albicans to pyrimidine biosynthesis in S. cerevisiae. We identified through this study that Ppr1 
has changed functions between the two species, but that the motif bound by Ppr1 in both species 
to carry out its transcriptional regulation role has been conserved. Dal82 is the transcriptional 
regulator of purine catabolism in S. cerevisiae and no transcriptional regulator has so far been 
identified for the pyrimidine biosynthesis pathway in C. albicans. We also point out that Ppr1 
rewired at the lineage leading to Naumovozyma castellii concomitant with the DAL cluster 
formation and the elimination of some oxygen consuming enzymes; events believed to have been 
driven by pressures to grow in low oxygen milieus. We therefore propose that the adaptation of 
species in the lineage leading to Naumovozyma castellii to grow in hypoxic conditions pressured 
Ppr1 to rewire at this point in the phylogeny. 
 In Chapter 3, we discuss the partial rewiring between C albicans and S. cerevisiae of the 
ZCF Stb5 and its suitability as a drug target. Stb5 regulates glyoxylate enzymes in C. albicans as 
well as drug efflux pumps, but regulates only drug efflux pumps in S. cerevisiae and not 
glyoxylate enzymes which appear to be under the control of Sip4 in S. cerevisiae. Our data show 
that stb5 null mutant C. albicans strains cannot efficiently utilize acetate as a sole carbon source 
(acetate catablism requires glyoxylate enzymes) and show sensitivity to the echinocandin drug 
class. In line with our discovery that Stb5 is required for drug resistance in C. albicans and also 
regulates the glyoxylate cycle that is very critical for virulence, we predict that drugs designed to 
inhibit Stb5 would prove efficient in treatment of candidiasis. 
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 In Chapter 4, we discuss a ZCF, Put3, that has preserved its primary function and has not 
been rewired between C. albicans and S. cerevisiae. We, however, discovered that C. albicans 
Put3 has fewer restrictions on carrying out its functions as compared to its S. cerevisiae ortholog. 
In both species, Put3 activates the transcription of Put1 and Put2, the two key enzymes of the 
proline degradation pathway, which leads to proline catabolism. Previous studies showed that S. 
cerevisiae can only degrade proline in the absence of a rich nitrogen source such as ammonium 
sulfate, and as soon as a rich nitrogen source becomes available, the proline degradation pathway 
gets shut down and degradation of the rich nitrogen source takes over. We report in this study 
that C. albicans Put3 degrades proline in the presence or absence of a rich nitrogen source such 
as ammonium sulfate in C. albicans. These findings highlight the ability of C. albicans to more 
























Chapter 2: Rewiring of the Ppr1 Zinc Cluster Transcription Factor 
from Purine Catabolism to Pyrimidine Biogenesis in the 
Saccharomycetaceae 
2.1 Preface 
 The work presented in Chapter 2 is from the following manuscript: Tebung, W. A., 
Choudhury, B. I., Tebbji, F., Morschhäuser, J. & Whiteway, M., (2016). Rewiring of the Ppr1 
Zinc Cluster Transcription Factor from Purine Catabolism to Pyrimidine Biogenesis in the 
Saccharomycetaceae. Curr Biol. 2016 Jun 15. pii: S0960-9822(16)30418-3. doi: 
10.1016/j.cub.2016.04.064. 
Author contributions: 
Walters Aji Tebung performed experiments, bioinformatic analyses, wrote paper; Baharul I. 
Choudhury carried out bioinformatic analyses; Faiza Tebbji contributed to the ChIP-Chip 
experiments; Joachim Morschhäuser provided activated transcription factor reagents; Malcolm 
Whiteway designed experiments, wrote paper. 
2.2 Abstract of manuscript 
 Metabolic pathways are largely conserved in eukaryotes, but the transcriptional regulation 
of these pathways can sometimes vary between species; this has been termed rewiring. Recently 
it has been established that in the Saccharomyces lineage starting from Naumovozyma castellii, 
genes involved in allantoin breakdown have been genomically relocated to form the DAL cluster. 
The formation of the DAL cluster occurred along with the loss of urate permease (UAP) and 
urate oxidase (UOX), reducing the requirement for oxygen and bypassing the candidate Ppr1 
inducer, uric acid. In Saccharomyces cerevisiae this allantoin catabolism cluster is regulated by 
the transcription factor Dal82, which is not present in many of the pre-rearrangement fungal 
species. We have used ChIP-Chip analysis, transcriptional profiling of an activated Ppr1 protein, 
bioinformatics, and nitrogen utilization studies, to establish that in Candida albicans the zinc 
cluster transcription factor Ppr1 controls this allantoin catabolism regulon. Intriguingly, in S. 
cerevisiae the Ppr1 ortholog binds the same DNA motif (CGG(N6)CCG) as in C. albicans, but 
serves as a regulator of pyrimidine biosynthesis. This transcription factor rewiring appears to 
have taken place at the same phylogenetic step as the formation of the rearranged DAL cluster. 
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This transfer of the control of allantoin degradation from Ppr1 to Dal82, together with the 
repositioning of Ppr1 to the regulation of pyrimidine biosynthesis, may have resulted from a 
switch to a metabolism that could exploit hypoxic conditions in the lineage leading to N. castellii 
and S. cerevisiae. 
2.3 Introduction 
 The regulation of gene expression is an important factor in the development of organisms, 
in the evolution of species, and in cellular adaptation to environmental changes. Although cells 
typically have conserved metabolic machinery, the regulation of genes encoding this machinery 
can vary, giving rise in part to the differences in phenotype that are observed among species [23]. 
Key components of eukaryotic gene expression control are the transcription factors (TFs) that act 
as transcriptional activators or repressors through binding to specific DNA sequences at the 
promoter regions of genes. These TFs fall into families, such as the basic helix loop helix 
(bHLH) class [1], the zinc finger TFs [2], the homeo box family [3], and the leucine zipper TFs 
[4]. 
 The zinc cluster TFs (ZCFs) are a subclass of the zinc-finger proteins found exclusively in 
fungi.  These ZCFs contain the conserved structural motif CX2CX6CX5–12CX2CX6–8C (where C 
represents cysteine, and X is any amino acid) [5,7,12,52,53]. This cysteine-rich sequence is 
generally located at the N terminus of the TF, and consists of 6 cysteines with typically a lysine 
residue between the second and third cysteines [8,9,13]. The entire DNA binding domain (DBD) 
of the transcription factor consists of the zinc finger, a linker region and a dimerization domain. 
Typically, ZCFs bind as homodimers using their zinc finger motifs to generate hydrogen bonding 
major groove interactions to CGG nucleotide triplets that are oriented in everted, inverted, or 
direct repeats [7,8]. The spacing of the CGG sequences is important for binding specificity, 
which is controlled by the number of generally non-conserved amino acids specifying both the 
ZCF's linker length and its folding [7,9-11]. The conserved cysteines serve to complex two zinc 
ions that are important in facilitating the DNA binding of the protein [12,13].  
These zinc cluster transcription factors are major components of fungal-specific regulatory 
circuits, and are known to control a multitude of processes as varied as metabolism, meiosis, 
virulence, and antifungal drug resistance [5-7]. A classic zinc cluster TF is the well-studied Gal4 
protein of S. cerevisiae. This protein served as the basis for the yeast 2-hybrid system [54], and 
studies have established its mechanism for dimerization [13,55], for binding to the specific DNA 
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sequence 5'-CGG(N11 )CCG-3' [13,55], and for interacting with other regulatory proteins to 
establish the inducibility of the yeast Leloir pathway genes to galactose [18,19].  This level of 
understanding has made S. cerevisiae Gal4 a popular model for systems biology investigations 
into eukaryotic transcriptional regulation [9,14,19,54]. Intriguingly, outside of the 
Saccharomyces lineage Gal4 orthologs can perform other functions, although they continue to 
bind the motif 5'-CGG(N11 )CCG-3'. For example, in C. albicans, the Gal4 ortholog binds 
glycolytic genes and subtelomeric TLO genes [14-17], and is not involved in galactose 
regulation. This represents an interesting example of transcription factor rewiring, the process 
whereby orthologous proteins, interacting with conserved binding sites, control different 
functions in related species [21]. Because the DNA binding sequences for ZCFs are short, genes 
can easily move in or out of regulatory circuits through changes in one or two nucleotides in their 
promoters. However, the driving forces behind such rewiring events are currently poorly 
understood.  
 Here we investigate the function of the zinc-cluster transcription factor Ppr1 in C. 
albicans.  Ppr1 was initially identified in S. cerevisiae where it bound the motif 5'-
CGG(N6)CCG-3' to regulate genes involved in the biosynthesis of uracil [56,57]. We show here 
that the Ppr1 ortholog in the opportunistic fungal pathogen C. albicans uses the same binding 
motif to regulate genes involved in allantoin degradation. Bioinformatic analysis of the promoter 
motifs within the fungal phylogeny suggest that this rewiring event resulted in a switch, within 
the Saccharomyces lineage, of the regulation of allantoin degradation from Ppr1 to Dal82. 
2.4 Materials and methods  
2.4.1 Strains, media, plasmids and transformation 
 We followed standard procedures for C. albicans cell growth and transformation [58]. 
YPD was used to culture C. albicans strains for transformation, immunoprecipitation, ChIP-Chip 
analyses and transcriptional profiling experiments. Yeast carbon base media (YCB) at 11.7 
mg/ml lacking a nitrogen supplement, or supplemented  with ammonium sulfate (37.82 mM), 
urea (10 mM) or allantoin (10 mM), was used for phenotype studies testing the ability of the ppr1 
null mutant to utilize allantoin as a nitrogen source.  
 The PPR1-TAP strain was constructed from strain SN148 [59,60] by transformation using 
a TAP-URA3 PCR product containing 99 base pairs (bp) of homologous sequence immediately 
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upstream and downstream of the PPR1 stop codon. The TAP-URA3 portion of the oligomer used 
for transformation was amplified from the pFA-TAP-URA3 plasmid [60] using the forward 
primer PPR1_TAP_URA3_F and the reverse primer PPR1_TAP_URA3_R (See table S1 for 
oligos). Correct integration of the TAP tag was confirmed by PCR using two primer pairs; 
forward primer PPR1_TAP_URA3_check_F that binds inside the PPR1 gene and reverse primer 
FT-U3 that binds inside the URA3 gene, and forward primer FT-U1 that binds inside the URA3 
gene and reverse primer PPR1_TAP_URA3_check_R that binds downstream of PPR1. The ppr1 
null mutant was constructed in strain SN95 by replacing one PPR1 allele with the HIS1 marker 
and the other allele with ARG4 marker. Oligonucleotides used for ppr1 null mutant construction 
were amplified from plasmids pFA-HIS1 for the first allele knockout and pFA-ARG4 for the 
second allele knockout [60] using the respective forward and reverse primers 
PPR1_Marker_KO_F that has a 97 bp region with homology just before the PPR1 start codon 
and PPR1_Marker_KO_R that has a 95 bp region with homology just after the PPR1 stop codon. 
Deletion of the first allele was confirmed by PCR using the forward primer PPR1_KO_Check_F 
that binds upstream of the PPR1 gene and the reverse primer PPR1_KO_Check_R that binds 
downstream of the gene. Deletion of the second allele was confirmed by PCR using two primer 
pairs; forward primer PPR1_KO_Check_F that binds upstream of the PPR1 gene and reverse 
primer FT-H2 that binds upstream of the HIS1 gene (HIS1 promoter region) and forward primer 
FT-U3 that binds inside the HIS1 gene and reverse primer PPR1_KO_Check_R that binds 
downstream PPR1. The ppr1 null mutants were confirmed using the forward primer 
PPR1_KO_Check_Internal_F and the reverse primer PPR1_KO_Check_Internal_R that both 
bind inside the PPR1 gene; no band is expected for ppr1 null mutants for this primer pair.  The 
SCPPR1GAD1A strain was as described previously [5]. 
2.4.2 Immunoprecipitation 
 The immunoprecipitation protocol was used as previously described [32] with the 
following modifications: a 700 μl lysate obtained from the cell culture was incubated with IgG 
Sepharose beads at 4°C overnight on a lab rotator. After transferring the proteins through 
Western blotting from a 12% SDS-PAGE gel to a nitrocellulose membrane, the membrane was 
treated with the primary rabbit polyclonal antibody (1:1000) directed against the TAP-tag, then 
with the secondary anti rabbit antibody coupled to dye IR 680 (1:5000). Protein bands were 




 The strain containing the chromosomally inserted PPR1-TAP fusion as well as the 
background strain SN148 (untagged) were grown to an optical density of 0.6 at 600 nm (OD 
600nm) in 50 ml of YPD. Crosslinking was performed by incubating each 50 ml culture with 1.5 
ml of 37% formaldehyde for 30 minutes; modified from 1.4 ml of 37% formaldehyde as 
described earlier [61]. Cultures were centrifuged for 5 mins in a 4°C centrifuge at 3600 RPM and 
YPD media removed by decantation, then cells were washed twice in 4°C cold TBS using 40 ml 
TBS each time. TBS was removed after every wash by decantation following a 5 min 
centrifugation at 3600 RPM in the centrifuge at 4°C. A final centrifugation was carried out at 
13000 RPM for a minute at 4°C before removing residual TBS, leaving cell pellets for the 
following steps. Cell pellets were resuspended in 700 µl lysis buffer (50 mM HEPES-KOH pH 
7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate) with protease 
inhibitors, and 0.5 ml acid washed glass beads (425 - 600 µm) were added. Samples were 
homogenized five times for a minute each at 4,200 RPM using a Bead beater with five minute 
breaks on ice between homogenization steps; this step was modified from the four rounds of 
homogenization described previously [61]. The lysate collected for each sample was sonicated 
using a Fisher Scientific Model FB120 sonicator to obtain DNA with an average length of 300-
500 bp (samples were sonicated four times for 20 seconds at Amp 35% and pulse 20, tubes were 
put on ice for at least a minute between every round of sonication) and all 700 μl of each lysate 
was incubated with IgG-Sepharose beads overnight, a modification of the 500 μl of lysate 
described previously [61]. The next day, beads from each sample were washed twice with 1 ml 
Lysis buffer, twice with 1 ml lysis buffer supplemented with 360 mM NaCl, twice with 1 ml 
Wash buffer (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 0.5% NP40, 0.5% Nadeoxycholate, 1 mM 
EDTA) and once with 1 ml TE (10 mM Tris pH 8.0, 1 mM EDTA), then incubated in 50 µl 
TE/SDS (10 mM Tris pH 8.0, 1 mM EDTA, 1% SDS) overnight at 65°C. 345 µl TE, 3 µl DNase-
free RNase A (10 mg/ml in water) and 2 µl glycogen (20 mg/ml) were then added to each 
supernatant and incubated for 2 hours at 37°C followed by the addition of 15 µl of 10% SDS and 
7.5 µl proteinase K (20 mg/ml) and then by a 2 hour incubation at 37°C. DNA isolation involved 
two 400 µl phenol/chloroform/isoamyl alcohol (25:24:1) extractions as described previously [61]. 
For DNA amplification and labelling, 40 µl of immunoprecipitated DNA for each sample was 
incubated for 20 minutes at 12°C with 70 µl of blunting mix (11 µl 10x NEB #2 buffer, 0.5 µl 
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BSA (10 mg/ml), 0.5 µl dNTPs (20 mM each dATP, dCTP, dGTP and dTTP), 0.2 µl T4 DNA 
polymerase and 57.8 µl ice-cold water) followed by the previously described DNA extraction 
protocol [61]. Extracted DNA for each sample was resuspended in 25 µl ice-cold water and 
incubated overnight at 16°C with 25 µl of ligase mix (8 µl water, 10 µl 5X ligase buffer, 6.7 µl 
annealed linkers, 0.5 µl T4 DNA ligase) [61]. Amplification PCR and indirect labeling with the 
appropriate dye, Cy5 or Cy3, was carried out as described [61] with the exception that OneTaq 
was used instead of Taq polymerase, and Vent polymerase used instead of Pfu polymerase. ChIP 
DNA from tagged strains was labeled with Cy5 dye and ChIP DNA from untagged strains SN148 
was labeled with Cy3 dye, and were then co-hybridized to Agilent 8X15K whole genome arrays 
containing 14490 60-mer intergenic and intragenic oligonucleotide probes. Microarray 
hybridization, washing, scanning, and normalization were performed as described [62] with the 
following modifications: scanning was done using the Axon GenePix 4000B microarray scanner, 
and data analyses and normalizations were done using GenePix data analysis software and 
Multiexperiment Viewer (MeV) software, with a 0.05 P-value cut-off for MeV analyses. 
Scanning settings used were 635 nm for Cy5 and 532 nm for Cy3. The log of ratios Cy5/Cy3 
(635 nm/532 nm) with a cut off of at least 1.5 for each spot was considered to be an indicator of 
significant Ppr1 binding. Data can be accessed online under the accession number GEO: 
GSE80343. 
2.4.4 Transcriptional Profiling Experiments 
 Transcriptional profiling experiments were carried out with strain SCPPR1GAD1A (Ppr1 
gain of function mutant) and the background strain SC5314 (wild type). Fresh colonies of each 
strain were each inoculated in 50 ml YPD and incubated overnight at 30°C on a 220 rpm shaker. 
The overnight cultures were diluted to OD600 of 0.1 in YPD and grown to an OD600 of 0.8. 
Total RNA was extracted using the QIAGEN RNeasy minikit protocol. Cell pellets were 
resuspended in 1 ml RNeasy buffer RLT with 10 µl β-mercaptoethanol, then 0.6 ml of acid-
washed glass beads (425 - 600 µm) were added before homogenizing each sample five times for 
a minute each at 4,200 RPM using a Bead beater, with five minute breaks on ice between 
homogenization steps. RNA was extracted from the collected lysate following the Qiagen 
RNeasy protocol. RNA quantity was determined using a NanoQuant machine. Twenty μg of total 
RNA from each sample was reverse transcribed using oligo(dT)23VN and Superscript III reverse 
transcriptase (Invitrogen) in the presence of Cy3 or Cy5 to achieve direct dye incorporation, and 
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dye swaps were employed for each sample. After cDNA synthesis, template RNA was degraded 
by adding RNase A (Sigma) to a final concentration of 0.05 mg/ml and 0.05 units/µl RNase H 
(New England Biolabs) to each sample and incubating for 30 minutes at 37°C before purifying 
the labeled cDNAs with a QIAquick PCR Purification Kit (QIAGEN). Hybridization, washing, 
scanning, and normalization were performed as described [62], with the exception that scanning 
used an Axon GenePix 4000B microarray scanner, and data analyses and normalizations were 
done using GenePix data analyses software. Scanning settings were 635 nm for Cy5 and 532 nm 
for Cy3. The median of ratios mutant-Cy5/non-tagged-Cy3 or Mutant-Cy3/non-tagged-Cy5 
values were statistically analyzed in the MultiExperiment Viewer (MeV) software using a p-
value cut-off at 0.05. Positive significant genes (upregulated genes) were candidates for Ppr1 
regulation. Data can be accessed online under the accession number GEO: GSE80343. 
2.4.5 Bioinformatics 
 A C. albicans whole genome motif scan for the S. cerevisiae Ppr1 motif was done using 
the Candida Genome Database (CGD) tool "Patmatch" (http://www.candidagenome.org/cgi-
bin/PATMATCH/nph-patmatch) [63]. Motif scanning was  performed using the software 
package MotifLab [64] for Ppr1 and Dal82 motifs, analyzing 500 bp promoter regions of the 
appropriate orthologous genes in different Ascomycetes species. Gene ontology analyses were 
done using the CGD tool "Go Term Finder" (http://www.candidagenome.org/cgi-
bin/GO/goTermFinder) [63].  DNA binding motifs were identified from ChIP-Chip data using 
the online motif search tool MEME (http://meme-suite.org/tools/meme) [65]. Fifty sequences 
corresponding to the top Ppr1 target genes identified by ChIP-Chip with log of ratios ranging 
from 2.70 to 9.08 were used for further analysis. We used 500 bp promoter region of the top 50 
genes to screen for potential motifs de novo using the online motif search tool MEME 
(http://meme-suite.org/tools/meme) [65]. The validity of predicted motifs was confirmed by 
performing motif overrepresentation analysis implemented in MotifLab [64]. In this analysis, the 
upregulated gene list is considered as 'target' and the rest of the genes in the C. albicans genome 
is considered as 'control' to compare the distribution of motif(s) between the two. The 
hypergeometric statistical test followed by Bonferroni correction as implemented in MotifLab 
[64] was applied to establish the validity of the candidate motif. Similarly, a potential motif for 
non-Ppr1 regulated URA genes (URA1, URA2, URA3, URA4, URA6, URA10) was predicted 
based on 500 bp promoter regions of C. albicans, C. dubliniensis, C. tropicalis and C. 
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parapsilosis using MEME [65] followed by motif overrepresentation analyses for each species. 
Fungal blast of C. albicans Ppr1 was done using the Saccharomyces Genome Database (SGD) 
fungal blast tool (http://yeastgenome.org/blast-fungal) [66]. Protein sequences were aligned using 
the SIM Alignment Tool (http://web.expasy.org/sim/) [67]. The LALNVIEW program was used 
to generate graphical representations of protein alignments [68]. 
2.4.6 Allantoin utilization assay 
 The ppr1 null mutant strain, SCPPR1GAD1A (Ppr1 gain of function strain) and SC5314 
(wild type strain) were each cultured in 11.7 mg/ml Yeast Carbon Base (YCB) (Sigma-Aldrich), 
YCB + allantoin (10 mM), YCB + ammonium sulfate (37.82 mM) and YCB + urea (10 mM) for 
3 days at 30°C in a Sunrise plate reader (TECAN) with a 220 rpm shaker. The plate reader was 
set to collect OD600 data every 10 minutes throughout the incubation period. 
2.5 Results 
2.5.1 Bioinformatic analysis of Ppr1 function in C. albicans uracil biosynthesis 
 An apparent ortholog of the S. cerevisiae PPR1 gene is encoded by the C. albicans gene 
C5_04970C_A (PPR1). These two orthologs have about 40% sequence identity throughout a 500 
amino acid N-terminal region containing the zinc cluster domain (Figure 2.1). The second best hit 
identified for CaPpr1 in S. cerevisiae was Stb5, which has a stretch of 100 amino acids with just 
over 30% identity located outside of the region containing the zinc cluster domain. ScPPR1 and 
C5_04970C_A thus represent reciprocal best hits, supporting C5_04970C_A as the Ppr1 ortholog 










Figure 2.1: C. albicans Ppr1 aligned with S. cerevisiae Ppr1. The left shaded alignment area has 38.10% identity 
and includes the zinc cluster domain. The bigger shaded alignment area to the right has 40.73% identity. 
 We used a bioinformatic approach to examine whether these proteins perform similar 
functions. Ppr1 regulates URA genes (URA1, URA2, URA3, URA4, URA6 and URA10) in S. 
cerevisiae using the Ppr1 binding motif 5'-CGG(N6)CCG-3' [56,69]. Motif scanning identified 
convincing Ppr1-binding sites at the promoter of URA genes in the Saccharomyces lineage from 
S. cerevisiae to N. castellii, but these sites were not found at the promoter of URA genes in C. 
albicans and other non-Saccharomyces fungi (Figure 2.2A). Rather, the Ppr1-binding site was 
found at the promoter of purine catabolism genes in the non-Saccharomyces species (Figure 2.2A 
and 2.2B). This observation suggested that the regulatory circuit controlled by Ppr1 differs 
between members of the Saccharomyces lineage and other fungi. Analysis of potential motifs in 
the promoter regions of the C. albicans URA genes has identified a possible enriched motif 
GryTkGwnTGGT in the promoters of several of the URA genes of Candida species and their 
close relatives (Figure 2.3). 
2.5.2 Direct identification of C. albicans Ppr1 target genes using ChIP-Chip 
 Chromatin immunoprecipitation followed by microarray analysis (ChIP-chip) is a 
powerful technique for identifying the direct binding targets of transcription factors. For our 
analysis, a TAP epitope sequence was fused to the endogenous PPR1 gene in strain SN148; 
correct DNA fusion was established using PCR and proper TAP-tagged protein expression was 
confirmed using immunoprecipitation. Chip results from the TAP-tagged strain were consistent 
with ChIP-Chip and microarray results from an HA-tagged Ppr1 strain; this, together with the 
phenotype of a ppr1 null mutant, implied that tagging Ppr1 did not affect its function. After 
chromatin cross-linking, target binding sequences were identified by amplifying and labeling 
immunoprecipitated DNA sequences and hybridizing these labeled sequences to Agilent 8X15K 
C. albicans whole genome tiling arrays. Ppr1 target genes were ranked based on their log of 
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ratios (PPR1-TAP-Cy5/non-tagged-Cy3) values (Table 2.1). Gene ontology assessment of genes 
corresponding to the top 150 targets with a log of ratios cut-off of at least 1.5 showed enrichment 
in genes involved in purine nucleobase catabolism (Table 2.1) suggesting that Ppr1 in C. albicans 





















Figure 2.2: Purine catabolism pathway, Ppr1 motif occurrence in the promoters of de novo pyrimidine 
biosynthesis and purine catabolism genes, and the presence or absence of DAL82 genes across the 
Ascomycetes. 
A) Ppr1 motif occurrence in the promoters of de novo pyrimidine biosynthesis (URA) and purine catabolism 
(includes DAL) genes, and the presence or absence of DAL82 genes across the Ascomycetes. Dark blue with motif 
logo represents Ppr1 motif; Grey boxes indicate gene presence; White boxes indicate gene absence; Blue box implies 
sequence is not available in databases; A= Dal82 Absent; P= Dal82 Present. The phylogenetic tree is based on [70] 
and Fungal Orthogroups Repository (http://www.broadinstitute.org/regev/orthogroups/). 
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B) Purine catabolism pathway [71]. Blue enzymes: present in C. albicans and regulated by Ppr1 but are missing in S. 
cerevisiae; Green enzymes: regulated by both Ppr1 in C. albicans and by Dal82 in S. cerevisaie. Red enzymes: 
regulated by Ppr1 in C. albicans and present in S. cerevisiae but not regulated by by Dal82 in S. cerevisiae. The 
dashed lines represent non-enzymatic reactions. 
 
2.5.3 Ppr1 DNA binding sequence in C. albicans 
 To identify a potential DNA binding motif for Ppr1 in C. albicans, the DNA sequences 
220 bp upstream and 220 bp downstream of each positive 60 bp probe, (a total of 500 bp per 
site), were analyzed [65]. The most probable motif for C. albicans Ppr1 detected from the top 50 
positive genes (Table S2) was CGG-X6-CCG (E-value=4.6E-004) (Figure 2.4A), which is 
identical to the reported motif for S. cerevisiae Ppr1 (Figure 2.4B) [56,69]. The motif was further 
confirmed by motif occurrence analysis that showed significant overrepresentation of the motif in 
target genes compared to the control (p-value 7.62 x 10
-13
). Thus the Ppr1 proteins of the two 
species bind the same DNA sequence, but this binding controls distinct functions. 
 
2.5.4 Transcriptional profiling experiments using a Ppr1 gain of function mutant 
 ChIP-Chip and bioinformatics analysis predicted that Ppr1 in C. albicans is a 




Figure 2.3: Occurrence of Ppr1 and non-Ppr1 motifs across the Ascomycetes fungi.  
The Ppr1 motif (green boxes) is present only throughout Saccharomyces species while an alternative 
GryTkGwnTGGT-like motif (yellow boxes) is present across the non-Saccharomyces species. The presence and 
absence of a promoter sequence is represented by grey and white boxes respectively. Motif scan was performed at 
the 90% threshold using the software package Motiflab. The phylogenetic tree is based on [70] and Fungal 




Table 2.1 C. albicans Ppr1 binding sites identified by ChIP-Chip 
ChIP-Chip data was analyzed using GenePix and MeV, and the top 15 Ppr1 target genes as well as genes in the top 
50 ChIP-Chip hits that are involved in purine catabolism or also appear in the transcriptional profiling results are 
presented in this table. Genes in black font appear in ChIP-Chip only, genes in red font appear as both ChIP-Chip 
and transcriptional profiling hits, and highlighted genes are involved in purine catabolism. URA3 frequently appears 
in ChIP-Chip data of our Tap-tagged strains when transformants are selected using the URA3 selectable marker; the 
reason for this is unclear. Primers used for transformation in this study are presented in Table S1. 
 




p-Value Function/Putative function 
 orf19.230 9.08 1 2.76E-06 Ortholog (Pet111) is a mitochondrial 
translational activator specific for 
COX2 mRNA 
MRV1 orf19.4691 6.87 2 0 Uncharacterized. No predictions. 
GCN4 orf19.1358 6.19 3 7.81E-04 bZIP transcription factor; amino acid 
control response 
  orf19.2065 5.42 4 6.90E-07 Ortholog (DAL2) involved in 
allantoin catabolism 
 orf19.2928 5.32 5 0.001922015 Ortholog(s) have COPI-coated 
vesicle, Golgi apparatus localization 
URA3 orf19.1716 4.80 6 6.90E-07 Orotidine-5'-phosphate 
decarboxylase; pyrimidine 
biosynthesis 
 orf19.77.1 4.73 7 6.21E-06 Protein of unknown function 
ETR1 orf19.5450 4.52 8 2.07E-06 Putative 2-enoyl thioester reductase 
 orf19.6272 4.36 9 2.76E-06 Putative ubiquitin C-terminal 
hydrolase 
ARG4 orf19.6689 4.18 10 0.010551414 Argininosuccinate lyase, catalyzes 
the final step in the arginine 
biosynthesis pathway 
 orf19.6480 4.05 11 0.011303658 Ortholog(s) have role in UDP-




SEC1 orf19.6479 4.05 11 0.011303658 Ortholog(s) have SNARE binding 
activity and role in upregulation of 
vesicle fusion 
 orf19.1043 4.04 12 4.83E-06 Ortholog(s) have lysophosphatidic 
acid acyltransferase activity 
 orf19.155 3.89 13 0.001272602 Functional homolog (Ure2p) 
regulates nitrogen utilization 
PWP1 orf19.4640 3.81 14 3.37E-04 Putative rRNA processing protein 
DAL1 orf19.5454 3.81 15 0.006016563 Putative allantoinase 
HBR2 orf19.1078 3.63 18 1.52E-05 Putative alanine glyoxylate 
aminotransferase 
  orf19.1681 3.62 19 1.59E-05 Closest protein in A. nidulans 
involved in purine utilization 
AHP2 orf19.6470 3.61 20 1.45E-05 Putative thiol-specific peroxiredoxin 
  orf19.2114 3.49 24 1.52E-05 Predicted uricase 
 orf19.4889 3.32 29 7.45E-04 Predicted MFS family membrane 
transporter, member of the 
drug:proton antiporter 
FCA1 orf19.4195.1 3.11 32 4.55E-05 Cytosine deaminase; enzyme of 
pyrimidine salvage 
  orf19.1421 2.91 37 9.73E-05 Ortholog (DAL3) involved in 
allantoin catabolism 
  orf19.3633 2.84 41 1.68E-04 Ortholog(s) have role in purine 
nucleobase catabolism 
CEF3 orf19.4152 2.80 44 2.45E-04 Translation elongation factor 3 
 orf19.5449 2.63 56 2.46E-04 Predicted integral membrane protein 
 orf19.6316 2.54 62 4.55E-04 Predicted membrane transporter 
ALG11 orf19.3468 2.47 68 5.85E-04 Alpha-1,2-mannosyltransferase 
 orf19.313 2.244 93 5.54E-04 Putative allantoin permease 
 orf19.1105 2.23 96 6.23E-04 Uncharacterized. No predictions. 
 orf19.1709 2.22 97 6.83E-04 Sterol carrier domain protein 
SAM50 orf19.7358 2.14 110 0.002341615 Predicted part of SAM complex, 
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mitochondrial protein import 
 
 
We transcriptionally profiled a C. albicans Ppr1 gain of function (GOF) mutant generated by 
addition of a Gal4 activation domain that artificially activates the TF [5], to establish the 
expression network of the transcription factor. Such GOF mutant strains can up-regulate 
networks in the absence of any stimulatory conditions. As shown in Table 2.2, transcriptional 
profiling experiments with the Ppr1 (GOF) mutant strain SCPPR1GAD1A identified six genes 
involved in purine catabolism among the top 11 overexpressed genes. These genes, which 
include a uricase and a variety of genes involved in allantoin catabolism, also feature among 17 
Ppr1 target genes appearing in the ChIP-Chip top 150 hits as well. PPR1 itself was presumably 
identified among the up-regulated genes because the hyperactive-allele-construct was driven by 
the strong ADH1 promoter. 
2.5.5 Allantoin utilization 
 To test for the role of PPR1 in purine catabolism predicted by the ChIP-Chip and 
transcriptional profiling experiments, we cultured ppr1 null mutants, control SC5314 (wild type 












Figure 2.4: Ppr1 DNA binding sequence in C. albicans and S. cerevisiae. 
A) C. albicans Ppr1 DNA binding motif based on top 50 Ppr1 binding sites from ChIP-Chip. ChIP-Chip identified 
sequences used to identify C. albicans Ppr1 DNA binding motif are presented in Table S2. 
B) S. cerevisiae Ppr1 DNA binding motif [57]. 
 
The ppr1 null mutant strain showed almost no growth after three days on allantoin as the sole 
nitrogen source, while SC5314 and SCPPR1GAD1A showed normal growth to saturation (Figure 
2.5A). This suggests that PPR1 is required for the expression of genes involved in allantoin 
catabolism. The GOF strain has a shorter lag phase than the wild type (Figure 2.5A), perhaps 
because the hyperactive Ppr1 more efficiently expresses genes required for growth on allantoin. 
All three strains were also cultured in YCB + ammonium sulfate as the sole nitrogen source 
(Figure 2.5B), YCB + urea as sole nitrogen source (Figure 2.5C), and YPD as controls. All 
strains showed normal and similar growth rates up to saturation in three days, suggesting that 
lack of growth of ppr1 null mutants in YCB + allantoin is due to the inability of the strain to 







Table 2.2: C. albicans Ppr1 upregulated genes identified by expression transcriptional profiling.  
Transcriptional profiling data were analyzed using GenePix and MeV, and the top 15 Ppr1 upregulated genes as well 
as genes appearing both in transcriptional profiling results and in the top 150 ChIP-Chip hits are presented in this 
table. Genes in black appear in transcriptional profiling hits only, genes in red or green appear in both ChIP-Chip and 
transcriptional profiling hits, promoters of genes in green are predicted by MEME to have the CGG(N6)CCG DNA 
binding motif, and highlighted genes are involved in purine catabolism. 
 




p-Values Function/Putative function 
PPR1 orf19.3986  21.879 1 0 ScPPR1 regulates uracil 
biosynthesis genes 
  orf19.2114 16.7755 2 1.55E-06 Predicted uricase 
  orf19.1421 16.239 3 1.55E-06 Ortholog (DAL3) involved in 
allantoin catabolism 
  orf19.2065 14.387249 4 1.55E-06 Ortholog (DAL2) involved in 
allantoin catabolism 
 orf19.3458 12.45425 5 1.66E-04 Ortholog(s) involved in late 
endosome to vacuole transport 
DAL1 orf19.5454 11.89975 6 3.10E-06 Putative allantoinase 
AHP2 orf19.6470 4.6359997 7 3.56E-05 Putative thiol-specific 
peroxiredoxin 
 orf19.6117 4.5480003 8 0.0082376 predicted auxin family 
transmembrane transporter 
ortholog 
  orf19.1681 4.19625 9 5.10E-04 Closest protein in A. nidulans 
involved in purine utilization 
 orf19.5713 3.92875 10 6.55E-04 Putative NADH dehydrogenase 
  orf19.3633 3.807 11 6.78E-04 Ortholog(s) have role in purine 
nucleobase catabolism 
 orf19.772.1 3.651 12 0.0091529 Uncharacterized. No predictions. 
 orf19.2796 3.5855 13 0.010271 Ortholog(s) have DNA 
polymerase, DNA replication 
activity. 
 orf19.413 3.49225 14 0.0066362 Protein of unknown function 
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SET2 orf19.1755 3.4105 15 0.0092396 Ortholog(s) have histone 
methyltransferase activity 
ALG11 orf19.3468 3.1995 26 9.43E-04 Alpha-1,2-mannosyltransferase 
 orf19.5449 2.13325 92 0.0041753 Predicted integral membrane 
protein 
 orf19.6316 2.085 93 0.0051293 Predicted membrane transporter 
CEF3 orf19.4152 2.08375 94 0.0151138 Translation elongation factor 3 
 orf19.1709 1.89925 107 0.0228512 Sterol carrier domain protein 
 orf19.1105 1.85 111 0.0096097 Uncharacterized. No predictions. 
FCA1 orf19.4195.1 1.617 132 0.0210485 Cytosine deaminase; enzyme of 
pyrimidine salvage 
 orf19.4889 1.5947499 135 0.0335326 Predicted MFS family membrane 
transporter 
SAM50 orf19.7358 1.5797501 144 0.0272991 Predicted part of SAM complex, 
mitochondrial protein import 
HBR2 orf19.1078 1.5035 154 0.0406117 Putative alanine glyoxylate 
aminotransferase 
 
2.5.6 Ppr1 regulation of other functions 
 In addition to genes implicated in regulation of allantoin catabolism, several other genes 
appear to be members of the Ppr1 regulon in C. albicans.  These include genes encoding such 
diverse functions as membrane transport, amino acid metabolism (aminotransferase function), 
translation elongation, mitochondrial protein import, sterol transport, glycosylation, 
antioxidation, and the pyrimidine salvage pathway (Table 2.2). Genes involved in these pathways 
appear in both transcriptional profiling results and the top 150 ChIP-Chip hits, and the Ppr1 
binding motif was identified at the promoter of some of the genes. Phenotype studies will be 
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Figure 2.5: Allantoin, ammonium sulfate and urea utilization assays of a C. albicans ppr1 null mutant strain, a 
Ppr1 gain of function mutant strain and the C. albicans wild type strain SC5314. Error bars are based on the 
standard deviation of the seven replicates of each data point reading taken every two hours. Primers used for 
transformation in this study are presented in Table S1. 
A) Growth curve of ppr1 null mutant (ΔΔppr1) strain, Ppr1 gain of function mutant (Ppr1-GOF) strain and SC5314 
(WT=wild type) strain in yeast carbon base (YCB) medium with allantoin as the sole nitrogen source. 
B) Growth curve of ppr1 null mutant strain, Ppr1 gain of function mutant strain and SC5314 strain in yeast carbon 
base medium with ammonium sulfate as the sole nitrogen source. 
C) Growth curve of ppr1 null mutant strain, Ppr1 gain of function mutant strain and SC5314 strain in yeast carbon 
base medium with urea as the sole nitrogen source. 
2.6 Discussion and conclusions 
 The zinc cluster transcription factor Ppr1 was initially identified in the yeast S. cerevisiae 
as a regulator of pyrimidine (uracil) biosynthesis, through its interaction with the motif 5'-
CGG(N6)CCG-3' found in the promoters of many of the regulated genes [56,69]. Our studies 
using motif searches, ChIP-Chip analysis and transcriptional profiling suggests that pyrimidine 
biosynthesis is not under the regulation of Ppr1 in C. albicans, and the Ppr1 null mutant strain 
grows normally on media without uracil. No specific transcription factor has been associated with 
the URA regulon outside of the Ppr1 regulated species such as S. cerevisiae, and it is possible 
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transcriptional profiling experiments done using SCPPR1GAD1A (Ppr1 in SCPPR1GAD1A 
strain is HA-tagged) show that Ppr1 does not bind and does not regulate the URA3 gene. 
However, motif searches have identified the sequence GryTkGwnTGGT enriched in the 
promoters of the genes of the URA regulon of C. albicans and its close relatives (Figure 3), and 
thus some yet to be defined transcription factor may be involved in the regulation of uracil 
biosynthesis in non-Saccharomyces species.  
 Although Ppr1 does not regulate the URA pathway in C. albicans, it has a clear function 
in this species. The C. albicans ortholog of Ppr1, encoded by the gene C5_04970C_A, uses the 
5'-CGG(N6)CCG-3' binding motif to control a regulon involved in purine catabolism, particularly 
allantoin degradation. ChIP-Chip results suggest that Ppr1 binds to the promoters of allantoin 
degradation and other purine catabolism genes (Table 2.1), and the upregulation of these target 
genes as shown in the transcriptional profiling results (Table 2.2) implies that Ppr1 binding leads 
to transcriptional activation of the target genes. The role of Ppr1 in purine catabolism was further 
confirmed by the inability of a ppr1 null mutant C. albicans strain to grow in YCB medium with 
allantoin as the sole nitrogen source (Figure 2.5A); these findings also suggest that Ppr1 could be 
the sole regulator of purine catabolism in the pathogen. Such dramatic rewiring of transcription 
factor function has been seen elsewhere within the fungi; examples include Gal4 rewiring [15], 
Mcm1 regulating cell cycle and mating in most yeast species, but co-regulating ribosomal gene 
expression with Rap1 in the C. glabrata, K. lactis, Y. lipolytica, and the A. nidulans lineages [33], 
and ribosomal protein gene expression regulated by Tbf1 in C. albicans but Rap1 in S. cerevisiae 
[31]. 
 Phylogenetic examination of the candidate motifs upstream of the allantoin degradation 
regulon and the URA biosynthesis regulon suggests that the shift of the Ppr1-binding motif 5'-
CGG(N6)CCG-3' from the promoters of allantoin catabolism genes to pyrimidine biosynthesis 
genes occurred in the lineage leading to N. castellii and the other Saccharomyces species. As 
shown in Figure 2a, there is essentially no evidence for the motif in the URA gene promoters in 
species outside the Saccharomyces species, but strong evidence for the motif in many of the 
genes within these species.  By contrast, the motif is commonly associated with the allantoin 
degradation pathway genes in many fungi outside of the Saccharomyces clade. 
 The timing of the Ppr1 rewiring event is intriguing, as this phylogenetic divergence 
corresponds to a massive genomic reorganization of the genes involved in allantoin degradation. 
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There is an initial scattered distribution in the non-Saccharomyces that shifts to a clustered 
distribution (the Dal cluster) in the Saccharomyces species [72]. In the clustered regulons 
transcriptional regulation of allantoin degradation is under the control of Dal82, a transcription 
factor that arose prior to the whole genome duplication but is not present in species such as C. 
albicans. In S. cerevisiae Dal82 forms a heterodimer with Dal81, and the complex binds 
sequences known as UISALL elements or Dal82 motifs (5'-AAANTTGCG-3') [73-75] to 
regulate allantoin degradation. Dal82 is induced to activate allantoin degradation genes in S. 
cerevisiae by allophanate, the last intermediate in the allantoin degradation pathway [73]. 
Although Dal81 is present in both Candida and Saccharomyces species, its role is different in C. 
albicans where it apparently positively regulates cell adhesion [76], and is therefore unlikely to 
interact with Ppr1 to regulate allantoin degradation. The presence or absence of the Dal82 motif 
at Dal gene promoters across yeast species suggests that Dal82 may have taken over purine 
catabolism in the lineage leading to N. castellii and relatives at the same time Ppr1 changed its 
function. In S. cerevisiae, nitrogen catabolite pathways are also under the positive regulation of 
Gln3 and Gat1 and the negative regulation of Dal80 and Deh1 which all bind 5' GATAA 3' 
sequences to activate or repress genes. Bioinformatic analysis of a candidate nitrogen catabolite 
repression circuit found that while the members of the circuit can vary among ascomycetes, there 
is no evidence that this circuit undergoes any transition corresponding to the switch from Ppr1 to 
Dal82 [77]. Concomitant with the Ppr1 rewiring event was the elimination of some oxygen 
consuming functions from both the purine catabolism and pyrimidine biosynthesis pathways [72]. 
The uric acid importer, uric acid permease, together with urate oxidase which uses molecular 
oxygen to break down uric acid, were both eliminated from the genome of S. cerevisiae and close 
relatives, together with other oxygen-demanding functions [72]. A specific allantoin permease 
gene, DAL4, arose from the duplication of the uracil permease gene, FUR4, at the same 
phylogenic time as the DAL cluster formation and Ppr1 rewiring [72]. Consequently, the 
Saccharomyces species shifted from importing uric acid, which demanded oxygen for its 
metabolism, to importing allantoin [72]. Allantoin is an important plant nitrogen storage and 
transport molecule, and thus would be relatively abundant in the yeast environment. The loss of 
these oxygen demanding enzymes at this point enhanced the ability of Saccharomyces species to 
grow effectively in hypoxic conditions. This strategy to minimize oxygen consumption through 
genomic editing is possibly the reason behind the clustering of the DAL genes [72], and is likely 
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the driving force that led to the the rewiring of Ppr1 and the introduction of the allophanate-
induced Dal82 to the purine catabolism pathway. Uric acid induces the Ppr1 orthologs of A. 
nidulans and N. crassa, UaY and PCO-1 respectively, which in both cases lead to the activation 
of purine catabolism genes [78,79]. Dihydroorotic acid, which is an intermediate in the 
pyrimidine biosynthesis pathway, has been shown to induce at least one of the activities under 
control of UaY in A. nidulans [78]. The switch from importing uric acid to importing allantoin in 
the Saccharomyces lineage eliminated the original Ppr1 inducer, uric acid. This could allow Ppr1 
to respond to the weaker inducer dihydroorotic acid, resulting ultimately in the switch from the 
regulation of purine catabolism to the regulation of de novo pyrimidine biosynthesis. The Ppr1 
function in purine catabolism regulation could be replaced by Dal82, a transcription factor 
induced by allophanate that is not present in species such as C. albicans, in the Saccharomyces 
lineage. Alternatively, a switch to a low oxygen environment could have blocked the availability 
of uric acid as a nitrogen source and made the oxidase and permease dispensable in the 
Saccharomyces species. Overall, these findings suggest that Ppr1 transitioned from regulating 
purine catabolism to the regulation of pyrimidine biosynthesis at the lineage leading to N. 
castellii and the other Saccharomyces species which coincides with the clustering of Dal genes, 











Chapter 3: Stb5 is a transcriptional regulator of genes involved in 
echinocandin resistance and the glyoxylate cycle in Candida albicans 
3.1 Preface 
 The work presented in Chapter 3 is from a manuscript under preparation: Tebung, W. A., 
Morschhäuser, J. & Whiteway, M., (2016). Stb5 is the transcriptional regulator of genes 
involved in echinocandin resistance and the glyoxylate cycle in Candida albicans. Target 
journal: Molecular Microbiology. 
Author contributions: 
Walters Aji Tebung performed experiments, bioinformatic analyses, wrote paper; Joachim 
Morschhäuser provided activated transcription factor reagents; Malcolm Whiteway designed 
experiments, wrote paper. 
3.2 Abstract of manuscript 
 Resistance to drugs is a prevalent problem posed by Candida albicans during the 
treatment of candidiasis. Understanding and countering the mechanisms used by C. albicans to 
fight off drugs is key to reducing the ever-rising annual deaths caused by the pathogen. Stb5 is a 
zinc cluster transcription factor (ZCF) and one of six STB (Sin Three Binding) proteins initially 
identified in Saccharomyces cerevisiae. Our findings using ChIP-Chip, transcriptional profiling, 
nutrient utilization assays and drug response assays suggest that the Stb5 ortholog in C. albicans 
regulates drug resistance genes, as well as components of the glyoxylate cycle. The role C. 
albicans Stb5 plays in the regulation of drug pumps correlates with a major role of Stb5 in S. 
cerevisiae where it regulates drug efflux pumps. Although some weak homodimerization has 
been reported for Stb5 in S. cerevisiae, Stb5 mostly binds DNA as a heterodimer with Pdr1 to 
regulate drug pumps in yeast. The absence of a Pdr1 ortholog in C. albicans suggests that Stb5 
may have ancestrally regulated drug resistance either as a homodimer or as a heterodimer with a 
transcription factor other than Pdr1, but evolved in S. cerevisiae to recruit the recently arisen Pdr1 
for this purpose. Actively pumping out drugs is a common mechanism used by C. albicans to 
evade drugs, making Stb5 a potential target against drug resistance. Stb5 apparently dropped its 
acetate catabolism regulation role at some point between C. albicans and S. cerevisiae, but took 
on other roles such as regulation of the expression of the pentose phosphate pathway genes, the 
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control of NADPH production for ensuring resistance to oxidative stress and the ergosterol 
biosynthetic pathway. 
3.3 Introduction 
 Pathogenic organisms are constantly in a battle to survive adverse conditions in the host. 
Some of the challenges faced by pathogens range from the need to fight off the host immune 
system, to resist drugs, and to adapt to alternate nutrient sources when preferred sources are 
limited or absent. C. albicans is a successful commensal and opportunistic pathogen that is a 
major cause of serious fungal infections of humans [80]. Current treatment of such infections 
(candidiasis) rely on the use of three major drug classes - the azoles, the polyenes and the 
echinocandins [81], but a growing resistance to these drugs by C. albicans calls for a need to 
identify novel treatment options, and to identify and counter mechanisms used by the pathogen to 
build resistance to existing drugs. A common azole resistance mechanism in C. albicans involves 
the induction of drug efflux pumps encoded by CDR or MDR genes, which results in the cells 
actively pumping out azoles to minimize the effect of the drug [82]. The newest class of 
antifungals, the echinocandins, have a broad spectrum of activity against Candida species [83], 
but C. albicans have been reported to build resistance against this class of antifungals through 
point mutations in the FKS genes encoding the major subunit of its target enzyme [82], and by 
actively pumping out echinocandins using Cdr2 [84], and, to a lesser extent, Cdr1 [84]. In 
addition to its ability to resist antifungals, C. albicans also thrives as a pathogen due to its ability 
to quickly adapt to alternate nutrient sources in the host [85], and its ability to evade the host 
immune mechanisms [86]. It has been reported that in low glucose environments, C. albicans 
relies on the glyoxylate cycle for survival [87]. The pathogen is able to grow in low nutrient 
milieus such as inside macrophages and neutrophils by utilizing alternate carbon sources through 
pathways such as the glyoxylate cycle [85], and has been shown to escape macrophages by 
switching to hyphal growth and breaking out of the phagocytic cell [88]. The role of the 
glyoxylate cycle in C. albicans pathogenesis has drawn recent attention to enzymes of the 
pathway such as Icl1 as potential drug targets [85]. 
 We report in this study a zinc cluster transcription factor, Stb5, which regulates the 
glyoxylate cycle, and confers resistance to echinocandins in C. albicans potentially by 
transcriptionally activating the expression of drug efflux pumps. Stb5 was first characterized in S. 
cerevisiae and is one of the six STB (Sin Three Binding) proteins [89]. STB proteins in S. 
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cerevisiae interact with the transcriptional repressor protein Sin3, hence the name STB. Stb5 in 
C. albicans, however, has so far not been linked to C. albicans Sin3 protein and has only adopted 
its name from the S. cerevisiae Stb5 ortholog. In S. cerevisiae, Stb5 ZCF is known to regulate 
multidrug resistance genes [90], genes of the pentose phosphate pathway, genes implicated in 
NADPH production for ensuring resistance to oxidative stress [91] and genes of the ergosterol 
biosynthetic pathway. Stb5 has therefore conserved a role in drug resistance between C. albicans 
and S. cerevisiae, but has lost its role in the regulation of the glyoxylate cycle which in S. 
cerevisiae now seems to be under the regulation of Sip4. Identifying a drug that can inhibit Stb5 
would shut down the glyoxylate cycle making C. albicans less virulent, and would shut down 
drug efflux pumps rendering the pathogen more sensitive to antifungal drugs. Our findings 
therefore propose Stb5 as a potential drug target against C. albicans pathogenesis and drug 
resistance. 
3.4 Materials and methods 
3.4.1 Strains, media, plasmids and transformation 
 We followed standard procedures for C. albicans cell growth and transformation [58]. C. 
albicans strains used for transformation, immunoprecipitation, ChIP-Chip analyses and 
transcriptional profiling experiments were cultured in YPD at 30°C. Yeast nitrogen base medium 
(YNB) at 6.7 mg/ml supplemented with glucose (20 mg/ml) or acetate (19.6 mg/ml) was used for 
phenotype studies to test for the ability of the stb5 null mutants to utilize acetate as a carbon 
source. Other control media used for stb5 null mutant phenotype studies were YNB at 6.7 mg/ml 
without a nitrogen supplement, and YPD. 
 The STB5-TAP strain was constructed by transforming the strain SN148 [59,60] using a 
TAP-URA3 PCR product containing 99 base pairs (bp) of homologous sequence immediately 
upstream and downstream of the STB5 stop codon. The TAP-URA3 region of the oligomer used 
to transform SN148 was amplified from the pFA-TAP-URA3 plasmid [60] using the forward 
primer STB5_TAP_URA3_F and the reverse primer STB5_TAP_URA3_R. Appropriate 
genomic integration of the oligonucleotide containing the TAP tag was confirmed by PCR using 
two primer pairs; forward primer STB5_TAP_URA3_check_F that binds inside the STB5 gene 
and reverse primer FT-U3 that binds inside the URA3 gene, and forward primer FT-U1 that binds 
inside the URA3 gene and reverse primer STB5_TAP_URA3_check_R that binds downstream of 
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STB5. The stb5 null mutant strain was constructed by replacing one STB5 allele with the HIS1 
marker and the other allele with the ARG4 marker in the SN95 strain. Oligonucleotides used for 
stb5 null mutant construction were amplified from plasmids pFA-HIS1 for the first allele 
knockout and pFA-ARG4 for the second allele knockout [60] using the respective forward and 
reverse primers STB5_Marker_KO_F that has a 97 bp region that is complimentary to the 
sequence just before the STB5 start codon and STB5_Marker_KO_R that has a 95 bp region that 
is complimentary to the sequence just after the STB5 stop codon. Successful deletion of the first 
allele was confirmed by PCR using the forward primer STB5_KO_Check_F that binds the 
promoter region of the STB5 gene and the reverse primer STB5_KO_Check_R that binds 
downstream of the gene. Deletion of the second allele was confirmed by PCR using two primer 
pairs; forward primer STB5_KO_Check_F that binds the promoter region of the STB5 gene and 
reverse primer FT-H2 that binds upstream of the HIS1 gene (HIS1 promoter region) and forward 
primer FT-H3 that binds inside the HIS1 gene and reverse primer STB5_KO_Check_R that binds 
downstream STB5. The STB5 null mutants were confirmed using the forward primer 
STB5_KO_Check_Internal_F and the reverse primer STB5_KO_Check_Internal_R that both 
bind inside the STB5 gene; as expected, no DNA amplification was found for stb5 null mutants 
using this primer pair.  The SCSTB5GAD1A strain was as described previously [5]. See table S1 
for oligos used in these studies. 
3.4.2 Immunoprecipitation 
 We followed the immunoprecipitation protocol previously described [32] with the 
following modifications: we incubated 700 μl lysate obtained from the cell culture with IgG 
Sepharose beads at 4°C overnight on a lab rotator. After protein transfer through Western blotting 
from a 12% SDS-PAGE gel to a nitrocellulose membrane, the membrane was treated with the 
primary rabbit polyclonal antibody (1:1000) directed against the TAP-tag, followed by treatment 
with the secondary anti rabbit antibody coupled to dye IR 680 (1:5000). Protein bands were 
detected using an Odyssey scanner at a wavelength of 700 nm. 
3.4.3 ChIP-Chip 
 We carried out ChIP-Chip experiments as described (Chapter 2 of this thesis) with a few 
modifications. Briefly, the strain containing the chromosomally inserted STB5-TAP fusion as 
well as the background strain SN148 (untagged) were grown to an optical density of 0.6 at 600 
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nm (OD 600nm) in 50 ml of YPD. Crosslinking for each 50 ml culture was done by incubating 
with 1.5 ml of 37% formaldehyde for 30 minutes, then ChIP was performed as described 
(Chapter 2 of this thesis). ChIP DNA obtained from tagged strains was labeled with Cy5 dye and 
ChIP DNA from untagged strains SC5314 was labeled with Cy3 dye, and were then co-
hybridized to Agilent 8X15K whole genome arrays containing 14490 60-mer intergenic and 
intragenic oligonucleotide probes. Microarray hybridization, washing, scanning, and 
normalization were carried out as described [62] with the following modifications: Axon 
GenePix 4000B microarray scanner was used for scanning, and data analyses and normalizations 
were done using GenePix data analyses software and Multiexperiment Viewer (MeV) software; a 
0.05 P-value cut-off was used for MeV analyses. Scanning settings used were 635 nm for Cy5 
and 532 nm for Cy3. The log of ratios Cy5/Cy3 (635 nm/532 nm) with a cut off of at least 1.5 for 
each spot was considered to be an indicator of significant Stb5 binding. 
3.4.4 Transcriptional Profiling Experiments 
 Transcriptional profiling experiments were carried out following the procedures described 
(Chapter 2 of this thesis). Briefly, single colonies of the strains SCSTB5GAD1A (Stb5 gain of 
function mutant) and SC5314 (wild type) were each inoculated in 50 ml YPD and incubated 
overnight at 30°C on a 220 rpm shaker. Overnight cultures were then diluted to OD600 of 0.1 in 
YPD and grown to an OD600 of 0.8. Total RNA was extracted using the QIAGEN RNeasy 
minikit protocol and quantified using a NanoQuant machine. Reverse transcription of 20 μg of 
the total RNA from each sample was done using oligo(dT)23VN and Superscript III reverse 
transcriptase (Invitrogen) in the presence of Cy3 or Cy5 to achieve direct dye incorporation, and 
dye swaps were done for each sample. Following cDNA synthesis, template RNA was degraded 
by adding RNase A (Sigma) to a final concentration of 0.05 mg/ml and 0.05 units/µl RNase H 
(New England Biolabs) to each sample and incubating for 30 minutes at 37°C before purifying 
the labeled cDNAs with a QIAquick PCR Purification Kit (QIAGEN). Hybridization, washing, 
scanning, and normalization were performed as described [62], with the exception of scanning 
chips with an Axon GenePix 4000B microarray scanner, and data analyses and normalizations 
done using GenePix data analyses software. Scanning settings used were 635 nm for Cy5 and 532 
nm for Cy3. The median of ratios mutant-Cy5/non-tagged-Cy3 or Mutant-Cy3/non-tagged-Cy5 
values were statistically analyzed in the MultiExperiment Viewer (MeV) software using a p-
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value cut-off at 0.05. Positive significant genes (upregulated genes) were considered to be 
regulatory targets of Stb5. 
3.4.5 Bioinformatics 
 Gene ontology analyses were carried out with the CGD tool "Go Term Finder" 
(http://www.candidagenome.org/cgi-bin/GO/goTermFinder) [63]. Fungal blast of C. albicans 
Stb5 was carried out using the Saccharomyces Genome Database (SGD) fungal blast tool 
(http://yeastgenome.org/blast-fungal) [66]. Protein sequence alignment was done using the SIM 
Alignment Tool (http://web.expasy.org/sim/) [67]. Graphical representations of protein 
alignments were generated using the LALNVIEW program [68]. 
3.4.6 Acetate Utilization Assay 
 The stb5 null mutant strain, SCSTB5GAD1A (STB5 gain of function strain) and SC5314 
(wild type strain) were each cultured in 6.7 mg/ml Yeast Nitrogen Base (YNB) (Bishop), YNB + 
acetate (19.6 mg/ml), YNB + glucose (20 mg/ml) and YPD for three days on a 220 rpm shaker in 
a 30°C incubator. Cells were cultured in 10 ml of each medium in 50 ml falcon tubes and OD600 
data were collected every 24 hours throughout the incubation period.  
3.4.7 Drug resistance assay 
 The stb5 null mutant strain, SCSTB5GAD1A (STB5 gain of function strain) and SC5314 
(wild type strain) were each cultured in YPD, YPD + 2 μg/ml caspofungin, YPD + 0.1 μg/ml 
anidulafungin and YPD + 1 μg/ml amphotericin B for five days on a 220 rpm shaker in a 30°C 
incubator. Cells were cultured in 10 ml of each medium in 50 ml falcon tubes and OD600 data 
were collected every 24 hours throughout the incubation period. 
3.5 Results 
3.5.1 Confirmation of Stb5 ortholog 
 Stb5 was initially characterized in S. cerevisiae and has an apparent ortholog in C. 
albicans encoded by the gene C1_01200W_A (STB5). As shown in Figure 3.1, these two 
orthologous ZCFs have about 53.5% sequence identity at the 21 amino acid N-terminal region 
containing the zinc cluster domain, as well as a 444 amino acid stretch with 40.8% identity that 
spans most of each ortholog at their C-terminal region. The second best hit identified by using 
blast to compare CaStb5 against all S. cerevisiae proteins was S. cerevisiae Ppr1, which has a 
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block of 102 amino acids with 30.4% identity that is located outside of the region containing the 
zinc cluster domain. These findings establish that C1_01200W_A is the structural ortholog of 
Stb5 in C. albicans. 
3.5.2  ChIP-Chip identification of Candida albicans Stb5 target genes 
 To carry out ChIP-Chip analyses, we fused the TAP epitope sequence to the endogenous 
STB5 gene in strain SN148; correct DNA fusion was established using PCR and proper TAP-
tagged protein expression was confirmed using immunoprecipitation. 
 
 
Figure 3.1: C. albicans Stb5 aligned with S. cerevisiae Stb5. The left shaded alignment area has 53.5%  identity 
and includes the zinc cluster domain. The bigger shaded alignment area to the right has 40.8% identity. 
 
The consistency observed between ChIP-Chip results from the TAP-tagged Stb5 strain, 
microarray results from an HA-tagged Stb5 strain and the phenotype of a Stb5 null mutant 
suggest that tagging Stb5 did not affect its function in any substantive way. Following cross-
linking and Stb5 target DNA extraction, target binding sequences were identified by amplifying 
and labeling the immunoprecipitated DNA sequences and hybridizing these labeled sequences to 
Agilent 8X15K whole genome tiling arrays representing the C. albicans genome. Stb5 target 
genes were ranked based on their log of ratios (Stb5-TAP-Cy5/non-tagged-Cy3) values (Table 
3.1). Gene ontology assessment of genes corresponding to the top 150 targets with a log of ratios 
cut-off of at least 1.5 showed enrichment in genes involved in acetate catabolism, as well as some 
drug transport genes (Table 3.1) suggesting that Stb5 in C. albicans may transcriptionally 
regulate genes involved in acetate catabolism and drug transport. 
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3.5.3 Transcriptional profiling experiments to identify genes regulated by C. albicans Stb5 
 We also performed transcriptional profiling experiments on a C. albicans Stb5 gain of 
function (GOF) mutant generated by addition of a Gal4 activation domain [5], to establish 
functionally the expression network of the transcription factor.  
 
Table 3.1: C. albicans Stb5 regulated genes from ChIP-Chip and transcription profiling. Both ChIP-Chip and 
transcriptional profiling data were analyzed using GenePix and MeV. Stb5 upregulated genes from transcriptional 
profiling with median of ratios of at least 2.076 are presented with their binding log of ratios values from ChIP-Chip. 
ChIP-Chip log of ratios of one or less indicate no binding. Upregulated genes that are not significantly bound by 
Stb5 are indirectly regulated by Stb5. Gene ontology of genes highlighted in green indicate acetate catabolism, as 
well as the glyoxylate cycle for ICL1 and MLS1. Gene ontology of genes highlighted in grey indicate drug transport. 
Genes highlighted in light grey could potentially function in drug transport. N/A means not anayzed by ChIP-Chip. 
Primers used for transformation in this study are presented in Table S1. 
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 orf19.4652 453.042 1 0 N/A N/A 
ICL1 orf19.6844 256.784 2 0 2.790 0.0014 
 orf19.6950 119.627 3 0.000662847 -0.394 0.6357 
 orf19.7554 118.090 4 6.19483E-06 2.902 0.0011 
 orf19.4612 114.078 5 6.19483E-06 2.884 0.0013 
 orf19.614 71.619 6 0.002456249 N/A N/A 
 orf19.1431 68.684 7 0.003887254 N/A N/A 
AOX2 orf19.4773 55.171 8 4.64612E-06 0.743 0.1456 
YOR1 orf19.1783 37.555 9 4.95586E-05 0.761 0.1376 
TES1 orf19.5217 35.540 10 5.73022E-05 0.003 0.3875 
MLS1 orf19.4833 33.316 11 0.00013164 2.884 0.0013 
QDR2 orf19.6992 30.888 12 0.000322131 1.414 0.0313 
 orf19.2195 28.225 13 0.001635435 -0.009 0.5939 
ATO7 orf19.1571 23.256 14 0.009409943 0.379 0.3401 
 orf19.616 22.776 15 0.008039338 N/A N/A 
 orf19.1867 21.753 16 0.000142481 2.337 0.0046 
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 orf19.4121 21.727 17 8.67276E-05 0.546 0.2072 
CTN1 orf19.4551 19.785 18 9.91172E-05 2.134 0.0537 
 orf19.3059.1 19.742 19 0.004570234 0.526 0.2409 
 orf19.6723 19.587 20 0.003120644 0.109 0.4962 
 orf19.175 18.311 21 0.002951835 0.218 0.4460 
 orf19.2049 18.123 22 0.012773735 1.009 0.1006 
 orf19.750 17.733 23 0.001973053 0.581 0.2316 
 orf19.5218 16.897 24 0.000201332 N/A N/A 
 orf19.1366 16.578 25 0.009025863 0.982 0.0564 
TPO3 orf19.341 8.550 79 0.025733313 0.528 0.2505 
TPO4 orf19.473 6.301 94 0.00210779 0.222 0.4542 
FLU1 orf19.6577 3.964 140 0.006050798 1.110 0.0757 
CDR1 orf19.6000 3.638 150 0.007553043 2.740 0.0194 
PDR16 orf19.1027 2.840 181 0.012564658 1.619 0.0209 
SGE11 orf19.4779 2.407 206 0.021602912 0.395 0.3307 
SGE13 orf19.3444 2.155 229 0.027302152 1.595 0.0241 
CDR4 orf19.5079 2.076 239 0.030693822 0.959 0.0909 
 
Such transcription factor (GOF) mutant strains can allow for network up-regulation in the 
absence of stimulatory conditions. In support of the pattern observed by the ChIP-chip analysis, 
upregulated genes identified in the Stb5 GOF strain were enriched in genes involved in drug 
resistance, as well as genes of the glyoxylate cycle enzymes, specifically genes involved in 
acetate catabolism (Table 3.1). Reported acetate catabolic genes such as ICL1, MLS1, orf19.1867 
(MAE1) and CTN1 are highly upregulated, ranking 2nd, 11th, 16th and 18th respectively, among 
the identified upregulated genes in the Stb5 GOF strain, and also show very strong Stb5 binding 
signal in the ChIP-Chip data. ORF19.7554 and CDR1 appear among at least nine drug export 
genes identified through transcriptional profiling and also have strong Stb5 binding signals with 
log of ratios higher than the 1.5 cut-off in our ChIP-Chip data (Table 3.1). Although Stb5 does 
not bind its own promoter as shown in our ChIP Chip data, it was identified among the up-
regulated genes in our transcription profiling data suggesting it indirectly regulates itself. Acetate 
catabolism genes and some drug pumps, including CDR1 that has been reported to export 
echinocandins to a certain extent, were identified through ChIP-Chip and transcriptional profiling 
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as Stb5 targets, suggesting an acetate catabolism role and a possible drug resistance role of STB5 
in C. albicans. 
3.5.4 Resistance to echinocandins 
 ChIP-Chip and transcription profiling results suggested that Stb5 is a transcriptional 
activator of certain membrane transporters and transmembrane proteins, some of which have 
been reported to play a role in drug resistance in C. albicans. Stb5 is involved in the regulation of 
the ABC-type plasma membrane transporter Yor1 among other genes involved in multidrug 
resistance in S. cerevisiae; our transcription profiling data show a strong signal that indicates 
Yor1 (orf19.1783) is regulated by Stb5 in C. albicans as well. Other drug transport genes such as 
CDR1, CR_09830W_A (orf19.7554) and QDR2 appear in both ChIP-Chip and transcription 
profiling data. We therefore cultured stb5 null mutants in various drugs at 30°C to identify any 
drug sensitivity of the strain. stb5 null mutants showed increased sensitivity to caspofungin (2 
μg/ml) (Figure 3.2A) and anidulafungin (0.1μg/ml) (Figure 3.2B) when compared to the wild 
type SN95, and the Stb5 gain of function mutant strain, SCSTB5GAD1A. The strain (stb5 null 
mutant) showed no sensitivity to amphotericin B. Pertubation of carbohydrate catabolism could 
influence echinocandin sensitivity since echinocandins act on the cell wall, however the 
upregulation of drug pumps by Stb5 identified in this study for the Stb5-GOF strain show 
significant correlation with echinocandin sensitivity observed for the stb5 null mutant strain and 
could be an indicator that Stb5 upregulates drug pumps in C. albicans to confer drug resistance. 
Stb5 function therefore confers resistance to echinocandins potentially by influencing drug 
pumps as predicted through ChIP-Chip and transcription profiling. All strains including the stb5 
null mutant strain showed similar growth in YPD at 30°C (Figure 3.2C), a control that confirms 
that the slow growth observed for stb5 null mutant in the presence of echinocandins is due to its 
sensitivity to this class of drugs. 
3.5.5 Acetate utilization 
 We identified through ChIP-Chip and transcriptional profiling that some of the key 






















Figure 3.2: Growth curves of ΔΔstb5, SN95 (WT=wild type) and Stb5-GOF with or without echinocandins. 
Primers used for transformation in this study are presented in Table S1. 
A) Growth curves of ΔΔstb5, SN95 (WT=wild type) and Stb5-GOF in YPD +2μg/ml caspofungin. 
B) Growth curves of ΔΔstb5, SN95 (WT=wild type) and Stb5-GOF in YPD +1μg/ml anidulafungin. 
C) Growth curves of ΔΔstb5, SN95 (WT=wild type) and Stb5-GOF in YPD. 
 
The findings were verified by culturing stb5 null mutants in YNB media with 19.6 mg/ml acetate 
as the sole carbon source at 30°C. stb5 showed slow growth relative to the wild type SC5314 and 
other control strains, SCSTB5GAD1A (Stb5 gain of function strain) and ppr1 null mutant (Figure 
3.3A). All strains showed about the same growth pattern in YPD at 30°C  (Figure 3.3B) and the 
stb5 null mutant showed better growth compared to Stb5-GOF strain at 30°C in medium with 
glucose as the sole carbon source (Figure 3.3C). It has been reported [92] that icl1 and mls1 null 
mutant strains each show slow growth at 30°C in medium with acetate as the sole carbon source, 
and grow even slower in the same media at 37°C. stb5 null mutants had the same growth pattern 
as icl1 and mls1 in media with acetate as the sole carbon source at both 30°C and 37°C (Figure 
3.3A, B and C and Figure 3.4A, B and C), which further supports that Stb5 is a transcriptional 






















Figure 3.3: Acetate utilization assay of a C. albicans stb5 null mutant strain, a Stb5 gain of function mutant 
strain, ppr1 null mutant (ΔΔppr1) and the wild type strain SC5314 at 30°C. YPD and YNB + glucose media 
are used as controls at 30°C. Primers used for transformation in this study are presented in Table S1.  
A) Growth curve of stb5 null mutant (ΔΔstb5) strain, Stb5 gain of function mutant (Stb5-GOF) strain, ppr1 null 
mutant (ΔΔppr1) and SC5314 (WT=wild type) strain in yeast nitrogen base (YNB) medium with acetate as the sole 
carbon source at 30°C. 
B) Growth curve of stb5 null mutant (ΔΔstb5) strain, Stb5 gain of function mutant (Stb5-GOF) strain, ppr1 null 
mutant (ΔΔppr1) and SC5314 (WT=wild type) strain in YPD at 30°C. 
C) Growth curve of stb5 null mutant (ΔΔstb5) strain, Stb5 gain of function mutant (Stb5-GOF) strain, ppr1 null 
mutant (ΔΔppr1) and SC5314 (WT=wild type) strain in yeast nitrogen base medium with glucose as the sole carbon 



























Figure 3.4: Acetate utilization assay of a C. albicans stb5 null mutant strain, a Stb5 gain of function mutant 
strain, ppr1 null mutant (ΔΔppr1) and the wild type strain SC5314 at 30°C. YPD and YNB + glucose media 
are used as controls at 37°C. Primers used for transformation in this study are presented in Table S1. 
A) Growth curve of stb5 null mutant (ΔΔstb5) strain, Stb5 gain of function mutant (Stb5-GOF) strain, ppr1 null 
mutant (ΔΔppr1) and SC5314 (WT=wild type) strain in yeast nitrogen base (YNB) medium with acetate as the sole 
carbon source at 37°C. 
B) Growth curve of stb5 null mutant (ΔΔstb5) strain, Stb5 gain of function mutant (Stb5-GOF) strain, ppr1 null 
mutant (ΔΔppr1) and SC5314 (WT=wild type) strain in YPD at 37°C. 
C) Growth curve of stb5 null mutant (ΔΔstb5) strain, Stb5 gain of function mutant (Stb5-GOF) strain, ppr1 null 
mutant (ΔΔppr1) and SC5314 (WT=wild type) strain in yeast nitrogen base medium with glucose as the sole carbon 
source at 37°C. 
3.6 Discussion 
 Inhibition of the glyoxylate cycle has been shown to render C. albicans significantly less 
virulent [93]. Key enzymes of the glyoxylate cycle include Icl1 and Mls1, and studies have 
shown that ICL1 null mutants of C. albicans are less virulent [93]. ICL1 has therefore been 
proposed as a potential drug target against candidiasis [85]. We report for the first time a zinc 
cluster transcription factor, Stb5, which positively regulates the glyoxylate cycle and drug efflux 
pumps in C. albicans. stb5 deletion mutant strains of C. albicans showed sensitivity to 
caspofungin and anidulafungin which are members of the FDA approved echinocandins 
antifungal drug class. stb5 null mutants also showed poor growth at 30°C and worse growth at 
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37°C on media with acetate as the sole carbon source. These findings correlate with genes bound 
by Stb5 as observed through ChIP-Chip, and also correlate with the upregulated genes observed 
in transcription profiling data from the Stb5 gain of function mutant strain SCSTBGAD1A 
(Table 3.1). Stb5 binds and upregulates transcription of the genes encoding the glyoxylate cycle 
enzymes isocitrate lyase (ICL1), malate synthase MLS1, carnitine acetyl transferase CTN1 and 
orf19.1867 (putative malate permease MAE1). These enzymes are required for acetate catabolism 
and this suggests why C. albicans strains with the STB5 deletion do not grow in medium with 
acetate as the sole carbon source. The reduced ability for stb5 null mutants to grow in medium 
with acetate as the sole carbon source at elevated temperatures makes the inhibition of Stb5 even 
more clinically relevant since human body temperature is 37°C.  Many drug pump genes, 
including genes encoding Cdr1 and Pdr16, are bound and upregulated by Stb5 as shown in ChIP-
Chip and transcription profiling data (Table 3.1). In S. cerevisiae, Stb5 binds as a heterodimer 
with Pdr1 to the promoter of multidrug resistance genes to confer drug resistance. Pdr1 however 
has no reported ortholog in C. albicans, implying that Stb5 binds to the promoter of its target 
genes in C. albicans either as a monomer, a homodimer or a heterodimer with a transcription 
factor other than Pdr1. What is intriguing however is that we could not find a characteristic zinc 
cluster binding site at the promoter of C. albicans Stb5 target genes, which left us with the open 
question: Does C. albicans Stb5 regulate its target genes using a motif different from the 
traditional ZCF CGG-type motif? YOR1, a reported target of Stb5-Pdr1 heterodimer in S. 
cerevisiae was also found to be upregulated by Stb5 in C. albicans. Also intriguing is the fact 
that, contrary to the Yor1 activator role of Stb5-Pdr1 observed in S. cerevisiae, Stb5 appears to 
interact with Pdr1 to negatively regulate ABC transporter genes including YOR1 in C. glabrata, 
as well other pleiotropic drug resistance genes such as CDR1 [94]. Stb5-Pdr1 is also found to 
negatively regulate azole resistance genes in Candida glabrata  [94].  However, only the 
pleiotropic drug response element (PDRE) of C. glabrata PDR1 (TCCACGGA/G) was found 
upstream of seven Stb5-Pdr1 target genes and no motif similar to that reported for Stb5 in S. 
cerevisiae (CGGN(c/g)TA) was found, which suggests the possibility that the negative regulatory 
role of C. glabrata Stb5 could be due to altered promoter occupancy of some transcriptional 
targets of C. glabrata Pdr1p. Stb5 clearly regulates drug efflux pumps in C. albicans as shown in 
this study, and while previous studies showed that Cdr2 is the major echinocandin efflux pump, 
Cdr1 also identified in this study, among other Stb5 regulated pumps, does pump out 
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echinocandins in C. albicans which could explain the increased sensitivity of stb5 null mutants to 
YPD medium containing caspofungin or anidulafungin. We did not observe any improved fitness 
of the Stb5-GOF relative to the WT strain SC5314 in the presence of echinocandins and this 
could indicate that a basal expression level of the drug pumps is enough to confer maximum 
resistance to echinocandins such that overexpression of the pumps does not lead to any 
significant change in drug resistance. Also, maybe the cell membrane can only accommodate so 
many drug pumps such that extra transcripts of drug pumps only end up degraded. The null has 
no Stb5 and therefore insignificant expression of drug pumps, which explains the sensitivity to 
the drug. There is a possibility that the ability of Stb5 to positively regulate genes encoding 
acetate catabolic enzymes Icl1 and Mls1 could also lead to the breakdown of the acetate 
component of caspofungin acetate rendering the drug ineffective; this model, however, may only 
apply to caspofungin but not anidulafungin which lacks an acetate component, making drug 
pumps the most likely cause of echinocandin resistance. This, together with the individual roles 
of drug pumps and the acetate catabolic pathway in the success of C. albicans as a pathogen links 
both pathways to C. albicans pathogenicity and could explain why a single transcription factor, 
Stb5, regulates both processes.  
 These studies show that inhibiting the ZCF Stb5 shuts down the glyoxylate cycle which is 
required for C. albicans to use alternate carbon sources in order to thrive as a pathogen, makes C. 
albicans less virulent and prevents C. albicans from building resistance against the most 
clinically used drug class against candidiasis, echinocandins. Stb5 could therefore make a 






Chapter 4: Put3 positively regulates proline utilization and ribosome 
biogenesis in Candida albicans. 
4.1 Preface 
 The work presented in Chapter 4 is from the following manuscript under preparation: 
Tebung, W. A., Omran, R. P, Morschhäuser, J. & Whiteway, M., (2016). Put3 positively 
regulates proline utilization and ribosome biogenesis in Candida albicans. Target journal: 
Molecular Microbiology. 
Author contributions: 
Walters Aji Tebung performed experiments, bioinformatic analyses, wrote paper; Raha Parvizi 
Omran contributed to phenotypic experiments; Joachim Morschhäuser provided activated 
transcription factor reagents; Malcolm Whiteway designed experiments, wrote paper. 
4.2 Abstract of manuscript 
 Cells have evolved regulatory mechanisms to ensure that they choose nutrient sources 
efficiently. We have used direct phenotypic studies, transcription profiling and ChIP-Chip 
analysis to investigate the role of the Put3 ortholog in the fungal pathogen Candida albicans. We 
show, using phenotypic studies, that in contrast to S. cerevisiae which can only utilize proline as 
a nitrogen source, C. albicans utilizes proline both as a carbon source and as a nitrogen source. A 
C. albicans put3 null mutant strain failed to utilize proline suggesting that Put3 is required for 
proline degradation in C. albicans, as in S. cerevisiae. The C. albicans put3 null mutant strain 
was able to grow efficiently with glutamate, a product of proline catabolism following the action 
of the enzymes Put1 and Put2, as the sole carbon or nitrogen source. This suggests that Put3 
controls proline catabolism by regulating the first and second enzymes of the pathway, Put1 and 
Put2 respectively. Our transcription profiling and ChIP-Chip data further confirmed that Put3 
transcriptionally regulates Put1 and Put2 in C. albicans as both enzymes were upregulated in a 
strain expressing a hyperactive Put3, and Put3 showed direct binding to the Put1 promoter in our 
ChIP-Chip data. Our phenotypic findings also show that in this fungal pathogen, Put3 directs the 
degradation of proline even in the presence of a good nitrogen source such as ammonia, which is 
in contrast to Put3 regulated proline catabolism in S. cerevisiae that can only occur in the absence 
of a rich nitrogen source. The zinc cluster transcription factor (ZCF) Put3 was initially 
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characterized in Saccharomyces cerevisiae as the transcriptional activator of Put1 and Put2. 
Although in general, direct binding of ribosome biogenesis genes by Put3 in C. albicans was not 
observed in our ChIP-Chip data, the expression of many ribosome biogenesis genes was shown 
to be altered in our transcription profiling data using the strain expressing the hyperactive Put3. 
This suggests that Put3 indirectly regulates ribosome biogenesis. Other C. albicans cellular 
processes identified in this study to be regulated by Put3 include carboxylic acid metabolism, and 
hyphal growth. 
4.3 Introduction 
 Every organism requires carbon and nitrogen for survival, but nutrient choices and 
nutrient assimilation mechanisms vary among species. C. albicans uses available galactose as a 
carbon source even in the presence of glucose in contrast to S. cerevisiae that shuts down the 
galactose catabolic pathway and uses glucose as a carbon source when both galactose and 
glucose are available [95]. Galactose is efficiently utilized as a carbon source only in the absence 
of glucose [95] in S. cerevisiae. Also, galactose catabolism is not regulated by Gal4 in C. 
albicans as it is the case in S. cerevisiae [15]. S. cerevisiae has the ability to acquire carbon and 
nitrogen from varying sources, but tends to pick and choose nutrient sources when presented with 
options [95,96]. This case of Gal4 transcriptional rewiring and metabolic dynamics observed 
between C. albicans and S. cerevisiae highlights the need to tread carefully when predicting 
protein function and the structure of metabolic pathways in related organisms based solely on 
orthologies with genes in model organisms. We studied the role of Put3 in C. albicans and our 
findings suggest that Put3 function has been fundamentally preserved between C. albicans and S. 
cerevisiae. However, we show that in contrast to S. cerevisiae, C. albicans uses proline both as a 
carbon and nitrogen source, unlike S. cerevisiae where Put3 only activates proline degradation in 
the absence of a rich nitrogen source. The presence of a rich nitrogen source does not prevent C. 
albicans Put3 from breaking down proline to acquire carbon for cell growth. Nitrogen catabolism 
has been shown to be hierarchical in S. cerevisiae; proline is not used as a nitrogen source in the 
presence of ammonium sulfate, even though both can serve as nitrogen sources [96]. Also, 
proline only serves as a sole nitrogen source in S. cerevisiae and not a sole carbon source or sole 
carbon and nitrogen source [97]. In S. cerevisiae, proline serves as an inducer of Put3, and 
available nitrogen sources dictate the phosphorylation of Put3 and hence fine-tune its activation 
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of Put1 and Put2 [96], an event that seems to be bypassed in C. albicans since the pathogen can 
still catabolise proline in medium containing ammonium sulfate. 
4.4 Materials and methods 
4.4.1 Strains, media, plasmids and transformation 
 Standard procedures for C. albicans cell growth and transformation [58] were followed. 
C. albicans strains for transformation, ChIP-Chip analyses and transcriptional profiling 
experiments were cultured in YPD. Yeast nitrogen base medium (YNB) at 6.8 mg/ml 
supplemented with glucose (20mg/ml), or proline (15.3mg/ml) was used for phenotypic studies 
testing for the ability of the put3 null mutant to utilize proline as a carbon source. Yeast carbon 
base medium (YCB) at 11.7 mg/ml supplemented with ammonium sulfate (5 mg/ml), or proline 
(8.7 mg/ml) was used for phenotypic studies testing for the ability of the put3 null mutant to 
utilize proline as a nitrogen source. The put3 null mutant strains were also cultured in control 
media (YNB at 6.7 mg/ml without a carbon supplement, YCB at 11.7 mg/ml without a nitrogen 
source and YPD). The SCPUT3GAD1A strain was constructed as described [5]. One PUT3 allele 
was replaced by transformation with the HIS1 marker and the other allele with the ARG4 marker 
in the SN95 background strain to obtain the put3 null mutant. Oligonucleotides used for put3 null 
mutant construction were amplified from plasmids pFA-HIS1 for the first allele knockout and 
pFA-ARG4 for the second allele knockout [60] using the respective forward and reverse primers 
(PUT3_Marker_KO_F that has a 97 bp region that is complimentary to the sequence just before 
the PUT3 start codon and PUT3_Marker_KO_R that has a 95 bp region that is complimentary to 
the sequence just after the PUT3 stop codon). Deletion of the first allele was confirmed by PCR 
using the forward primer PUT3_KO_Check_F that binds upstream of the PUT3 gene and the 
reverse primer PUT3_KO_Check_R that binds downstream of the gene. Deletion of the second 
allele was confirmed by PCR using two primer pairs; forward primer PUT3_KO_Check_F that 
binds upstream of the PUT3 gene and reverse primer FT-H2 that binds upstream of the HIS1 
gene (HIS1 promoter region) and forward primer FT-U3 that binds inside the HIS1 gene and 
reverse primer PUT3_KO_Check_R that binds downstream PUT3. The put3 null mutants were 
confirmed using the forward primer PUT3_KO_Check_Internal_F and the reverse primer 
PUT3_KO_Check_Internal_R that both bind inside the PUT3 gene; no band is expected for put3 
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null mutants for this primer pair. Oligos used for transformation in this study are presented in 
Table S1. 
4.4.2 Proline Utilization Assay 
 The put3 null mutant strain, SCPUT3GAD1A (Put3 gain of function strain), SC5314 
(wild type strain) and the unrelated ppr1 null mutant strain were each cultured in 10 mls of one of 
the following media in 50 ml falcon tubes for 3 days at 30°C with shaking at 220 rpm (6.8 mg/ml 
Yeast Nitrogen Base (YNB), YNB + proline (15.3 mg/ml), YNB + glucose (20 mg/ml) and 
YPD). OD600 data were collected every 24 hours throughout the incubation period. 
 The put3 null mutant strain, SCPUT3GAD1A (Put3 gain of function strain), SC5314 
(wild type strain) and unrelated ppr1 null mutant strain were each cultured in 10 mls of the 
following media in 50 ml falcon tubes for 3 days at 30°C with shaking at 220 rpm (11.7 mg/ml 
Yeast Carbon Base (YCB) (Sigma-Aldrich), YCB + proline (8.7mg/ml) and YCB + ammonium 
sulfate (5mg/ml)). OD600 data were collected every 24 hrs throughout the incubation period. 
4.4.3 Transcriptional Profiling Experiments 
 Transcriptional profiling experiments were carried out as described (Chapter 2 of this 
thesis) with a few exceptions. Briefly, transcriptional profiling experiments were performed for 
the strain SCPut3GAD1A (Put3 gain of function mutant) versus the background strain SC5314 
(wild type). Single colonies of each strain were each inoculated into 50 ml YPD and incubated 
overnight at 30°C on a 220 rpm shaker. The overnight cultures were diluted to OD600 of 0.1 in 
YPD and grown to an OD600 of 0.8. Total RNA was extracted using the QIAGEN RNeasy 
minikit protocol and RNA quantity was determined using a NanoQuant machine. For direct dye 
incorporation, 20 μg of total RNA from each sample was reverse transcribed using 
oligo(dT)23VN and Superscript III reverse transcriptase (Invitrogen) in the presence of Cy3 or 
Cy5; dye swaps were employed for each sample. Template RNA was eliminated from the 
synthesised cDNA by simultaneously adding RNase A (Sigma) to a final concentration of 0.05 
mg/ml and 0.05 units/µl RNase H (New England Biolabs) to each sample, then incubating for 30 
minutes at 37°C before purifying the labeled cDNA with a QIAquick PCR Purification Kit 
(QIAGEN). Hybridization, washing, scanning, and normalization were performed as described 
[62], with the following exceptions. Scanning was carried out using an Axon GenePix 4000B 
microarray scanner, and data analyses and normalizations were done using GenePix data analysis 
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software. Scanning settings were 635 nm for Cy5 and 532 nm for Cy3. The median of ratios 
mutant-Cy5/non-tagged-Cy3 or Mutant-Cy3/non-tagged-Cy5 values were statistically analyzed 
in the MultiExperiment Viewer (MeV) software using a p-value cut-off at 0.05. Positive 
significant genes (upregulated genes) were candidates for Put3 regulation. 
4.4.4 ChIP-Chip 
 ChIP-Chip experiments were performed as described (Chapter 2 of this thesis) with minor 
changes. Briefly, the SCPUT3GAD1A strain containing the chromosomally inserted Put3-HA 
fusion as well as the background strain SC5314 (untagged) were cultured to an optical density 
(OD) of 0.6 at 600 nm in 50 ml of YPD. Crosslinking for each 50 ml culture was carried out in 
1.5 ml of 37% formaldehyde for 30 minutes, then ChIP performed as described (Chapter 2 of this 
thesis). ChIP DNA extracted from tagged strains was labeled with Cy5 dye and ChIP DNA from 
untagged strains SC5314 was labeled with Cy3 dye, and were then co-hybridized to Agilent 
8X15K whole genome arrays containing 14490 60-mer intergenic and intragenic oligonucleotide 
probes. Microarray hybridization, washing, scanning, and normalization were performed as 
described [62] with the following modifications: Axon GenePix 4000B microarray scanner was 
used to perform scanning, and GenePix data analysis software and Multiexperiment Viewer 
(MeV) software were used to analyse and normalise data; a 0.05 P-value cut-off was used for 
MeV analyses. Scanning settings used were 635 nm for Cy5 and 532 nm for Cy3. The log of 
ratios Cy5/Cy3 (635 nm/532 nm) with a cut off of at least 1.5 for each spot was considered to be 
an indicator of significant Put3 binding. 
4.4.5 Bioinformatics 
 The CGD tool "Go Term Finder" (http://www.candidagenome.org/cgi-
bin/GO/goTermFinder) [63] was used for Gene Ontology analyses. Fungal blast analysis of C. 
albicans Put3 was performed using the Saccharomyces Genome Database (SGD) fungal blast 
tool (http://yeastgenome.org/blast-fungal) [66]. Protein sequences were aligned using the SIM 
Alignment Tool (http://web.expasy.org/sim/) [67], and graphical representation of protein 




4.5.1 Bioinformatic determination of Put3 ortholog in C. albicans 
 The proposed ortholog of S. cerevisiae Put3 in the pathogen C. albicans is encoded by the 
gene C1_07020C_B (PUT3). These two orthologs have about 41.7% sequence identity that spans 
821 amino acids (over 83% of each protein) at the N-terminal part of each ortholog (Figure 4.1). 
The next closest S. cerevisiae protein in terms of sequence identity to CaPut3 is Asg1 which has a 
stretch of 214 amino acids with just 24.8% identity and that does not include the zinc cluster 
domain. These findings provide strong support that C1_07020C_B is the structural ortholog of 




Figure 4.1: C. albicans Put3 aligned with S. cerevisiae Put3. The shaded alignment area has 41.7%  identity and 
includes the zinc cluster domain. 
4.5.2 Proline utilization 
 Our phenotypic studies show that C. albicans is able to metabolize and use proline as a 
sole carbon source and is able to use proline in the presence or absence of ammonium sulfate, an 
observation that contrasts with findings that S. cerevisiae cannot use proline as a sole carbon [97] 
and can only use proline as a nitrogen source in the absence of a rich nitrogen source such as 
ammonium sulfate. Proline degradation is controlled by Put3 in S. cerevisiae, and this 
degradation is not activated when a better source of nitrogen is available [96,98]. This nitrogen 
sensing regulation of Put1 and Put2 by Put3 is achieved by fine-tuning Put3 activity through 
phosphorylation patterns that depend on the quality of available nitrogen in the growth medium 
[96,98]. Rich nitrogen sources induce phosphorylation patterns that inactivate the ability of Put3 
to induce proline catabolism genes. The C. albicans wild type strain SC5314 and the unrelated 
disruption ppr1 null mutant strain (the ppr1 null mutant strain was constructed similarly to the 
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put3 null mutant strain) showed significant growth in yeast nitrogen base (YNB) medium (The 
YNB medium contained ammonium sulfate) that contained 15.3 mg/ml proline as the sole carbon 
source.  This shows a more liberal use of proline by the pathogen as potentially both a carbon and 
a nitrogen source  (Figure 4.2A). To establish if Put3 regulates the proline degradation process in 
C. albicans, we cultured the wild type as well as the put3 null mutant and Put3 gain of function 
mutant (Put-GOF) strains for 5 days at 30°C in YNB medium containing 15.3 mg/ml proline as 
the sole carbon source. The put3 null mutant strain did not grow in YNB with proline as the sole 
carbon source after 5 days at 30°C, suggesting the inability of the strain to metabolize proline 
(Figure 4.2A), while the Put3-GOF showed a better growth rate compared to the wild type strain 
SC5314 and the control ppr1 null mutant strain (Figure 4.2A). These findings suggest that Put3 
regulates proline catabolism in C. albicans. All strains had normal and similar growth patterns in 
YNB with 20 mg/ml glucose as the sole carbon source (Figure 4.2B), and in YPD; and all strains 
showed no growth in YNB without a carbon source. We also used 8.7 mg/ml proline as a sole 
nitrogen source in yeast carbon base (YCB medum) to culture wild type C. albicans strain 
SC5314, the control ppr1 null mutant strain, the put3 null mutant strain and the Put3 gain of 
function strain. All strains were able to grow in the medium except the put3 null mutant strain 
(Figure 4.3A), indicating that Put3 regulates the use of proline both as a carbon source and a 
nitrogen source in C. albicans. All strains showed similar growth in YCB medium with 5 mg/ml 








Figure 4.2: Proline utilization as carbon source assay of a C. albicans put3 null mutant strain, the wild type 
strain SC5314, a Put3 gain of function mutant strain and ppr1 null mutant (ΔΔppr1) strain at 30°C. YNB + 
glucose media is used as a control at 30°C. Primers used for transformation in this study are presented in Table S1.  
A) Growth curve of put3 null mutant (ΔΔstb5) strain, SC5314 (WT=wild type) strain, Put3 gain of function mutant 
(Put3-GOF) strain and ppr1 null mutant (ΔΔppr1) in yeast nitrogen base (YNB) media with proline as the sole 
carbon source at 30°C. 
B) Growth curve of put3 null mutant (ΔΔstb5) strain, SC5314 (WT=wild type) strain, Put3 gain of function mutant 
(Put3-GOF) strain and ppr1 null mutant (ΔΔppr1) in yeast nitrogen base (YNB) media with glucose as the sole 
carbon source at 30°C. 
 
4.5.3 Identification of Put3 regulated genes using transcriptional profiling experiments  
 To identify the pathway through which Put3 regulates proline degradation in C. albicans, 
we did transcriptional profiling experiments using the Put3 gain of function mutant strain 
SCPUT3GAD1A, generated by addition of a Gal4 activation domain to Put3 [5]. Such gain of 
function (GOF) mutant strains can allow for network up-regulation in the absence of any 
stimulatory condition. Transcription profiling using hyperactive transcription factors is an 











Figure 4.3: Proline utilization as nitrogen source assay of a C. albicans put3 null mutant strain, the wild type 
strain SC5314, a Put3 gain of function mutant strain and ppr1 null mutant (ΔΔppr1) strain at 30°C. YCB + 
ammonium sulfate media is used as a control at 30°C. Primers used for transformation in this study are presented 
in Table S1.  
A) Growth curve of put3 null mutant (ΔΔstb5) strain, SC5314 (WT=wild type) strain, Put3 gain of function mutant 
(Put3-GOF) strain and ppr1 null mutant (ΔΔppr1) in yeast carbon base (YCB) media with proline as the sole 
nitrogen source at 30°C. 
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B) Growth curve of put3 null mutant (ΔΔstb5) strain, SC5314 (WT=wild type) strain, Put3 gain of function mutant 
(Put3-GOF) strain and ppr1 null mutant (ΔΔppr1) in yeast carbon base (YCB) media with ammonium sulfate as the 
sole nitrogen source at 30°C. 
 
The key proline catabolism enzymes Put1, and Put2 (median of ratio = 2.20325, P-value = 
0.022913117), were among the genes upregulated in strains expressing the hyperactive Put3 
(Table 4.1). This suggests that Put3 has preserved its proline catabolism regulation role between 
C. albicans and S. cerevisiae, and it regulates this pathway by transcriptionally activating Put1 
and Put2. Other upregulated genes observed in the transcription profiling data using the Put3 gain 
of function mutant strain are genes involved in ribosome biogenesis, carboxylic acid metabolic 
processes, filamentous growth, response to stress, RNA metabolic process, and cellular protein 
modification among others (Table 4.1). 
 
Table 4.1: C. albicans Put3 regulated genes from ChIP-Chip and transcription profiling. Both ChIP-Chip and 
transcriptional profiling data were analyzed using GenePix and MeV. Put3 upregulated genes from transcriptional 
profiling that also show Put3 binding in ChIP-Chip data are presented. 
 
Gene orf 
Transcription profiling ChIP-Chip 
Median of 
ratio P-values log of ratios P-values 
 orf19.670.2 28.522 0 1.557 0.014703244 
YHB1 orf19.3707 8.709 1.08409E-05 2.465 0.19247757 
GLN1 orf19.646 7.447 5.2656E-05 1.588 0.006385783 
PTC8 orf19.4698 6.080 8.82763E-05 2.519 1.13E-04 
PUT1 orf19.4274 4.452 0.000717051 2.308 9.52E-04 
CYB2 orf19.5000 3.882 0.001373703 1.512 0.08496411 
ATP1 orf19.6854 3.727 0.001810438 1.537 0.016077295 
IDP2 orf19.3733 3.300 0.003476847 3.738 0.019314699 
 orf19.1486 2.819 0.00730525 1.921 0.027921325 
 orf19.1549 2.753 0.009056837 2.148 0.1706846 
 orf19.4405 2.727 0.020243147 1.667 0.004911663 
 orf19.6853 2.668 0.009055289 1.537 0.016077295 
 orf19.5026 2.368 0.016391512 1.691 0.016881298 
 66 
 
RGT1 orf19.2747 2.351 0.017607247 1.644 0.048810214 
FAD2 orf19.118 2.236 0.023882609 2.038 0.004570739 
 orf19.1109 2.162 0.041091837 1.559 0.014572118 
 orf19.4273 2.144 0.038977854 2.222 0.00168116 
UTP4 orf19.1633 2.113 0.029476538 1.847 0.003489993 
 orf19.2782 2.037 0.033253834 1.920 0.17685506 
 orf19.3585 2.034 0.033969335 1.693 0.20605038 
 orf19.6828 2.009 0.04790305 1.563 0.10103865 
RPL35 orf19.5964.2 1.993 0.016881298 1.633 0.005551415 
GIN4 orf19.663 1.967 0.040771257 1.869 0.051601104 
CAS1 orf19.1135 1.947 0.044322442 1.555 0.04001725 
 
4.5.4 Direct identification of genes bound by Candida albicans Put3 using ChIP-Chip 
 Phenotypic studies revealed that Put3 regulates proline degradation in C. albicans and 
transcription profiling experiments revealed that C. albicans Put3 regulates the proline 
catabolism genes Put1 and Put2, as well as genes involved in ribosome biogenesis and other 
cellular pathways. Chromatin immunoprecipitation followed by microarray analysis (ChIP-Chip) 
effectively identifies the direct binding targets of specific transcription factors. This analysis was 
carried out using the C. albicans strain SCPUT3GAD1A [5], constructed from SC5314 and has 
an HA epitope sequence fused to PUT3 gene. After chromatin cross-linking, target binding 
sequences were identified by amplifying and labeling immunoprecipitated DNA sequences and 
hybridizing these labeled sequences to Agilent 8X15K whole genome tiling arrays representing 
the C. albicans genome. Put3 target genes were ranked based on their log of ratios (PUT3-HA-
Cy5/non-tagged-Cy3) values, then target genes with log of ratios of at least 1.5 that are also 
upregulated in the SCPUT3GAD1A strain expressing a hyperactive Put3 [5] (Table 4.1) were 
further analyzed for function using the Candida Genome Database Gene Ontology tool. 
Consistent with transcription profiling data for the SCPUT3GAD1A strain, Put3 targets identified 
by ChIP-Chip include Put1, an essential enzyme of the proline catabolism pathway, as well as 
genes involved in ribosome biogenesis, carboxylic acid metabolic processes, filamentous growth, 
response to stress, RNA metabolic processes, cellular protein modification among others (Table 
4.1). Put2, however, was not bound by C. albicans Put3 as shown in our ChIP-Chip data and this 
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could imply that Put3 regulates Put2 indirectly. Binding of C. albicans Put3 to the promoter of 
Put1 further confirms that C. albicans Put3 regulates proline catabolism in the pathogen, a role 
that is also played by its ortholog in S. cerevisiae. 
4.6 Discussion 
 We did phenotypic studies using a C. albicans put3 null mutant and found that this mutant 
showed no growth in YNB medium containing proline as the sole carbon source (Figure 4.2A), 
and no growth in YCB medium containing proline as the sole nitrogen source (Figure 4.3A). In 
contrast, the wild type strain SC5314, the Put3-GOF strain and ppr1 null mutant strain used as 
controls all showed significant growth in both YNB medium containing proline as the sole 
carbon source (Figure 4.2A) and YCB medium containing proline as the sole nitrogen source 
(Figure 4.3A). Intriguingly, the Put3-GOF strain had a shorter lag phase in YNB medium with 
proline as the sole carbon source, which further highlights the importance of Put3 in proline 
catabolism (Figure 4.2A). All strains showed similar growth in YNB medium containing glucose 
as the sole carbon source (Figure 4.2B), YCB media containing ammonium sulfate as the sole 
nitrogen source (Figure 4.3B), YNB with glucose as the carbon source, and YPD.  
Put3 regulates proline use as a nitrogen source in S. cerevisiae by controlling expression of PUT1 
and PUT2, which encode the steps required to process proline to glutamate. We found that 
glutamate complements the C. albicans put3 null mutant for both carbon and nitrogen needs, 
suggesting a requirement of Put3 to express the PUT1 and PUT2 genes for proline utilization. We 
further present transcription profiling and ChIP-Chip data to support the role of Put3 in the 
positive regulation of PUT1 and PUT2. 
 We therefore report here that the zinc cluster transcription factor Put3 has conserved its 
proline catabolism role between the related species C. albicans and S. cerevisiae, however, C. 
albicans is able to use proline both as its sole carbon source (Figure 4.2A) and as its sole nitrogen 
source (Figure 4.3A) which is contrary to S. cerevisiae that only uses proline as its sole nitrogen 
source but not as its sole carbon source or sole carbon and nitrogen source [97]. We also show 
that C. albicans degrades proline even in the presence of ammonium sulfate (Figure 4.2A), 
something S. cerevisiae cannot do. We further confirmed the role of Put3 in C. albicans using 
transcriptional profiling and ChIP-Chip experiments. Consistent with our observations from 
phenotypic studies, in C. albicans, Put1 and Put2 are under the regulation of Put3 as shown by 
our transcriptional profiling data, and our ChIP-Chip data suggest that Put3 binds PUT1 (Table 
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4.1); PUT2 does not appear to be bound by Put3 in C. albicans as suggested by our ChIP-Chip 
data. These findings suggest that PUT1 and PUT2 are under direct and indirect regulation of Put3 
respectively in C. albicans, unlike in S. cerevisiae where Put3 regulates both genes through direct 
binding [96]. Put3 also regulates ribosome biogenesis genes, carboxylic acid metabolic process, 
filamentous growth, the response to stress, RNA metabolic processes, and cellular protein 
modification among others as revealed by our transcription profiling and ChIP-Chip data (Table 
4.1). These other roles have so far not been reported for S. cerevisiae Put3, therefore, it will be 
neccesary to carry out phenotypic studies in order to finalyze the role of C. albicans Put3 in the 
pathways, and to establish whether or not S. cerevisiae Put3 plays a role in the processes. Such 
findings would either further strenghthen the proposed conservation of Put3 function, or reveal 
hidden cases of rewiring in Put3 function. 
 Our findings show that C. albicans uses proline both as a carbon source and nitrogen 
source, and that C. albicans Put3 regulates proline catabolism even in the presence of ammonium 
sulfate to provide the cells with carbon and nitrogen, events that are contrary in S. cerevisiae 
which can only use proline as a nitrogen source and whose Put3 does not possess the ability to 
effectively activate the proline catabolic pathway in the presence of a rich nitrogen source such as 
ammonium sulfate. Put3 is therefore not rewired, at a general level, between C. albicans and S. 
cerevisiae because its function remains the same in both C. albicans and S. cerevisiae, however, 
the ZCF is less tightly controlled in C. albicans and also plays a role in the breakdown of the 








Chapter 5: General conclusions and future work 
 Our research aims were to identify zinc cluster transcription factor rewiring between C. 
albicans and S. cerevisiae. We identified several scenarios regarding transcriptional rewiring 
presented in Chapters 2, 3 and 4 of this thesis.  
 Chapter 2 of this thesis is about Ppr1, a ZCF initially characterized in S. cerevisiae. Ppr1 
binds CGG(N6)CCG in S. cerevisae to regulate transcription of genes involved in de novo 
pyrimidine biosynthesis. A clear structural otholog of Ppr1 exists in the human pathogen C. 
albicans and one would expect, considering the structural similarity, that the two orthologous 
ZCFs will play the same role in the two species. We found otherwise. In C. albicans, Ppr1 
regulates Dal genes involved in purine catabolism using the same DNA binding motif, 
CGG(N6)CCG, as in S. cerevisiae. Among other transcriptional rewiring cases is the example of 
the ZCF Gal4 that regulates glucose utilization in the pathogen but drives galactose catabolism in 
the bread yeast. Transcriptional rewiring helps explain, at least in part, how species with similar 
genomes survive in their different home environments. However, little is known about the forces 
that drive transcriptional rewiring. We identified that Ppr1 rewired at the lineage leading to N. 
castellii under pressures to minimize oxygen use in S. cerevisiae and related species. How 
cellular systems copy and paste transcription factor binding sequences from the promoters of 
multiple genes in their old regulon to the promoter of a completely new gene set in their new 
regulon remains a mystery. More work would be required to address this question. 
 In Chapter 3, we discuss a case of partial transcriptional rewiring. Stb5 initially identified 
in S. cerevisiae as the regulator of drug efflux pumps, is found in our C. albicans studies to 
regulate not only drug efflux pumps, but also glyoxylate enzymes. Glyoxylate enzymes appear to 
be under the regulation of Sip4 in S. cerevisiae. The glyoxylate cycle has been proven important 
for C. albicans survival during pathogenesis. Enzymes of the glyoxylate cycle such as ICL1 
allow the pathogen to freely use non-fementable carbon sources such as acetate when glucose is 
limited during pathogenesis. Researchers have therefore proposed ICL1 as a drug target against 
candidiasis. Stb5 transcriptionally regulates ICL1 and drug efflux pumps and could potentially 
serve as a drug target. Stb5 will make a drug target because it controls two pathways, the 
glyoxylate and drug resistance pathways, that are both important for C. albicans virulence, and it 
is a member of the fungal specific class of transcription factors called zinc cluster transcription 
factors which should help in the development of antifungal drugs with minimal off targets in the 
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human host. Transcription factors would make excellent drug targets for cell destruction due to 
their involvement in multiple pathways. However, this promiscuous nature of transcription 
factors makes it challenging to use them as drug targets in the treatment of diseases that require 
cell healing due to extensive side effects. Other challenges faced when considering TFs as drug 
targets is the difficulty of finding drugs that would specifically disrupt protein-DNA interaction 
or protein-protein interaction, rather than a drug that simply binds the active site of an enzyme to 
inhibit its function [99]. Advances in Protein-DNA and protein-protein interaction studies have, 
however, led to the discovery of TF-targeting small molecules such as nutlins, which are specific 
MDM2-p53 antagonists currently in the early clinical trials for cancer treatment [100]. These 
advances in the understanding of protein-DNA and protein-protein interactions will allow for the 
exploitation of transcription factors as drug targets. C. albicans transcription factors such as 
Lys144, Sut1, Efg1, Crz1, Nrg1and many others have been identified as potential antifungal drug 
targets but have not actually been targeted [99]. Research on the identification of drug targets that 
are TFs, as well as drugs against these transcription factors would therefore improve the 
efficiency to fight candidiasis and diseases overall. 
 Chapter 4 is about Put3 that has conserved its function between S. cerevisiae and C. 
albicans. Put3 transcriptionally regulates proline catabolism in both species. We, however, 
discovered that C. albicans uses proline both as a carbon source and nitrogen source and also 
degrades proline even in the presence of ammonium sulfate. These findings are in contrast to S. 
cerevisiae that does not use proline as its sole carbon source or sole carbon and nitrogen source 
[97], but only uses proline as its sole nitrogen source. Also, the S. cerevisiae Put3 ortholog only 
degrades proline if no rich nitrogen source is available, contrary to C. albicans Put3. These 
differences could be a result of post-transcriptional regulation as we find the transcriptional 
arrangement in both species to be identical. It would be interesting to identify how C. albicans 
escapes the inhibition of Put3 that occurs in the presence of a rich nitrogen source such as 
ammonia, as observed in S. cerevisiae. 
 We would still need to screen the remaining of the 82 ZCFs in C. albicans in order to 
have an overall picture of how different organisms use rewiring to deal with challenges 
encountered in their lifestyle. Other points requiring more study to fully address transcriptional 
rewiring include the identification of the driving force or forces of rewiring, the importance of the 
rewiring process for evolution, whether or not transcription factors rewire randomly, and how 
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cells coordinate the seemingly complicated transfer of transcription factor binding sites from one 
gene set involved in a specific cellular process to a completely different gene set involved in a 
different cellular process. Is it coincidence that transcription factors seem to rewire between 
related cellular processes (Gal4 for the sugars and Ppr1 for nucleotides)? 
 Current knowledge of transcriptional rewiring can only partially address questions 
such as how and why transcription factors rewire, and whether or not rewiring is random. As 
evidenced in Gal4 and Ppr1 studies, it is unlikely that transcriptional rewiring is a random 
process. The respective transfer of Ppr1 and Gal4 DNA binding sites from one related gene set to 
another supports a more ordered process and dismisses the likelihood that transcriptional rewiring 
is random. Several transcriptional rewiring driving forces have also been identified. Some 
examples of rewiring drivers include horizontal gene transfer [41], gene duplication [42] and 
change of inducers (as reported for Ppr1 in Chapter 2 of this thesis). A fungal transcription factor, 
SB5, originating from a virus through horizontal gene transfer took over the transcriptional 
regulation of the cell cycle from the original transcriptional regulator E2F [41]. This highlights 
how horizontal gene transfer could drive transcriptional rewiring. A transcriptional rewiring 
event driven by gene duplication involves MALR that ancestrally binds CGC and CGG to 
regulate maltose utilization as well as palatinose utilization, but has evolved two paralogues 
following gene duplication that regulate distinct pathways. One of the MalR paralogues binds 
CGC to regulate maltose utilization, meanwhile the other paralogue binds CGG to regulate 
palatinose utilization [42]. Finally, we also report for Ppr1 in Chapter 2 of this thesis how 
changing the inducer of a transcription factor could drive rewiring. These findings indicate that 
many factors could induce transcriptional rewiring and further research would uncover many 
more driving forces that could help in the understanding of how and why transcription factors 
rewire.  
 In many rewiring cases, a transitional stage where two transcription factors compete for 
the same function often seem to precede the rewiring event. We identified a fairly equal 
distribution of the Ppr1 and Dal82 motifs at the promoter of Dal genes in species just before Ppr1 
rewiring which could suggest that both transcription factors compete for the regulation of Dal 
genes in those intemediary species. Also, Before SBF and Whi5 took over cell cycle regulation 
from E2F and Rb in fungi, they all co-existed in many basal fungi and the lineages formerly 
known as 'zygomycetes' and could suggest that both competed for cell cycle regulation before the 
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rewiring event [41]; in fact, SBF and E2F have the same DNA binding specificity which further 
strenghthens this hypothesis [41]. Finally, the two paralogues of MalR covered for each other in 
the transitional species around Saccharomyces bayanus just before the rewiring event that led to 
the pathway specialization of each of the paralogues [42]. These findings suggest that many 
pressures can initiate transcriptional rewiring, but a transcription factor can only rewire if another 
transcription factor takes over its ancestral role. This conclusion, however, may not apply to all or 
most cases of rewiring and it is only through extensive research covering most rewiring cases that 
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Appendix: Supplemental material 
 
Table S1: Oligos used for DNA amplification in these studies.  
Related to Table 2.1, Figure 2.5, Table 3.1, Figue 3.2, Figure 3.3, Figure 3.4, Figure 4.2, Figure 4.3 and Figure 4.4.   
 











































































Table S2: Top 50 Ppr1 ChIP-Chip Sequences submitted to MEME to identify Ppr1 DNA binding motif.  
Related to Figure 2.4A, Chapter 2. 
ChIP-Chip identified top 50 sequences corresponding to C. albicans Ppr1 target genes used used to 
identify C. albicans Ppr1 DNA binding motif 
>orf19.230 
AAATAATATTGTTGATGATTAATTACAGAAAAGAATTCATTCTATACATAAATATATATATAT
ATATACATATATTTATATTTATGTACATATATATATCTATATGAGAAAAATTAAACTATTTAC
AAAAAAAAAGTTCATAAAATTCAATCTCAATGGTAAGCAGTACTACCTATTATTATTATCTTT
CCATTGATTTAAAATATAAATTGTTTTATCAATTAATTCCATTATTTCATTTTCATCATTTTCC
AACATTAATTTAACATCACCTATAAAATGACGTAATTTCATTAAAGATTTTTTACCTTCCCCC
AATAATAATAATAATGATGATGATGATGATGATTCTTGATCATCAACATCATCTAATGAGTTA
TTATTATTATTAGTAGTAGTAGTAGTAGTGCTACTCTTCTGTATTGATCGTAATTTCTTGAATA
ACATATTTTCAATTAATAAAGTTTGATCTAATAAATATGGAGTTAAATAAATTTGTT 
>orf19.4691 
TTTGATATGTACAGTGAATGATCCCCCCTCACATTATGGTACATTCCATCATCATTCAAAAAG
AGATTTTTTTTAATAATAATGAATTATATTATGTAATCAAAAACCAATCAAATTTCAAGAGAC
TTCTACAAGAATATAATATGTGGAGTAATTTTAAGGTCTTTTATATTCTAACAAATTAGTAAC
TAATAATTATACCCAAATGAAAGTAATTCACTTGGAATAACACTCAAACTATAGTTAATTGTT
TAAGAAAAGGAAAATAATATATTTCCGTAAATAGATCATATATTTAACAAACTAAGATTTAT
TGATGAGCGAATATGAAAAGGAGAGAATCTTAATGTTTTGTTTCACAACTTTTACGAACTTTT
TTTTTTTTATTTAATGTGAATCACCCAAAACTTAACATTAATGAGTATGGAGTTCTTTCTTCTT
GAGCCTGTTTTGTCAACCACTGTACTGGTTGAATCAAGGGTAATGAGGATGTAGTCTGT 
>orf19.1358 
AACTACTGATTTTTTTGTGTTAAATTAATTTATTCACCACAAGGACACGACTATCCTACACTC
ACATACAAAAAAATTTATTAACAACAACAACAACAACAACAGCAGCAGCAGGGAGAGAGAG
AGATAAAAAAAAATTTTTCATTATAAAATCAACAAGAAATAACCTTGCGCTTAAAAAAAGTT
GAATAAAATTTCCTCTTTTTCTTCTTCTTCTTCTTTCTCTTACTAATTACACCAATTATATAATT
AAGAACAAAGTAACATAACAACAACAACAACTACTACTACTACTATTACTATTACTACTACG
TCTTAAATCTGCTATAAACTTATCATAAATTATTATTATTTATTATTTACCCCTTTTTTATTCAT
TATATTGTCCAAATTTTTTCCAAGATTATATACATTAGAAAAAATGTGTGCCTAAATTTATTT
ACCCTTGTAATACAATAAATTTGTTTATTAATTAATTAGAAAAAAAAAGTTGTTTTGTT 
>orf19.2065:orf19.2064 
TGTATATTGTGAAACAATTTGCTTTTGAAAGTCGTCTTGAGAAAGAATTTTGGTCATCGAAAA
TGCTTTAAATAATGTTTAAAAAAAGTTATGTGTGATTATATAAAATATCATATATGCAATTGT
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AGAAAGGAGATCTCCACCAATTTATAGTTGAAAGAGTTTTGAAAAATCCAATCTTTGATTCG
GGGTTGTCCGAGACAAACTTCCTATTGATAGTCGCACAGTTTGCCGAATTAGATGTTAGATTG
GTAGCGCCAGGTACACCACAATTGGAAATAAATCCCGCCAACAATTGTTTGGCAATTAAGTG
ATAGCAGCTTTCAAATACGATAGTATCGTACATATTACGAAGATCTTTTAATAGTTAACGAA
ATACAAGTGTACATAAAAATATATGCGAGCCCATTTGAGCCAAATCAAGTAAACTACATCGT
GAATAATCATGTATAAAGCGCCCATCGGTTTTATCTTTGACTTTTATAGCCGATCAGTACCCC 
>orf19.2928 
ATCACTCCTCTTCCTCCTATTATCAGACCACCCACCACCACCACCAATAACTAACAAACCTAC
AATTACATAACAAATAAAACAAACAAACAAAAAATACTGTATACATATAGATAGATAGATA
GATAGATAGATAAAAACAAGTAATATATTTATGTATATATATAAAAACAACTGTGTAATAAT
AATAATAATGATAATATAATAATATAATATGAAAAAAAAAGAAAAAACAAAAACTAATATA
TAAAGTTACATTTGGAAATAATCCTTTCCCCCGTTTTACTGTTTTTTATTTTCTTTTCTTCTTTT
CAAAAAAAAAATTCTTAAAAAAAAAACAAAAACCAAAATTTATGAATAAATGAAATAATTA
TAAATGAATAAACCACTTCCGCTCCCCCACTTAATCTCTTAAACTCTTAAACTCTGAATGGAT
TTGTAGAATAAGGGGTGGTACTTCCAGTAAAACGAGTACTCAAATAACTCCAAGTGTAGGTT
TT 
>orf19.77.1 
TAGTAGTGCAATTTAGTAAGCAAGTTGGCTAAAAAAGAAAAAAAAGAAGAATTTTTTTTAAA
TTACACAAAACCAAATAATAATAATAATAATTTTTTTTTTTTACGTGTCTTATTATTTAAATCA
ATTTAAAGTATCATGCACCCACTTCATCCACCCATCCATTTTTTAATGATATATCAAACATTC
CCTCTCTTCTTCAACTTCAACTTCTACTTGTTGTAATTGAAAGCTTCTACTTATAGATTAAAGA
TAGTTCTTTATGCAAATAATTTAACTAAAATCTATTTACTTTCACTCTAAATTATATAAATTGA
AATCAATAAATAAATAAAAGAACAGTAGGACTTGTTAGTTAATAAGACTTCATATAATTAAA
CAATAAATGAATTTAGAAAAAAAAAAAAAAACAGGTGGAAGGTTGTTGTTGTTTATTGTATT
CTATTAAAGGAAAAGGAGAGATGGGATTAGAGGTTTCTAGTTTCCATTTTGTATGTTCA 
>orf19.5450 
CAACACTCTAGTCGATGATAATGCTCGTGACATGGTTGCCTGATAAGAGAAAGAAAACTACT
AAGGTCGACGAAATTTTTACAATATATATATTTTTTGAGATAAACTTTTTTTTCTCTTTGTGTA
ACGATTCGGTTTTGGCCGAAACACTCATCGGGATGCGAGGCCCACTAGTATGTGATCAATTG
TTTACCCGATTTAGAATTGGCTACCCCATCTTTATACAACTCATGCAATTCCTTGCTACCATCA
AATCTCGTCTCGGTCGATTTCGCATCTTTTAATTCACCAGACTCGTACCATTCAATGATTTGAT
TCAATGTCTTCAACTTCAATTCCCTATTGTGTTTCAACAACTCAGTCACCCAGAACCCAGCAC
TAGTAAAGTTCTTGAAAATGTGTAATGACGTAGGAATGGTTACTGGCTGGAATGACATCCCA
CCATAAGTCAACATCAACCCGTTATTGTTCAATTTTCTGGCAATACCAGTAGAACTTTT 
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>orf19.6272 
ACCTCAAGATTTAATCATTTCAAATTCTAAATTATCACAATTAAGAAATAATTTGACCAAAGT
TAAGGAATTTTCTATTGATGATCGAGCAAAAATTATTGAAAATTTAGAAAATGATATTAAAT
TAGATGAAAATTTTGGTGAAAAAGGTGATACTAAAGCTCCTGATATTAATGAATCAGTTGAT
TTACATTTTATTTCATTTATTAAAAGTACGAAAAATGGTCATTTATATGAATTGGATGGTAGA
AGAACTGGTCCTATTGATTTAGGTGAGTCGAATAACAAGGACAATAATAATAATAATAATAA
TATTATTAATGATCCTTTATTGATTGAAAAAATTCAATTTTATATTGATAATGCTGATGAAGC
AAATAAAAATAATTTTGCAATTATGGCTATTGGTCCTTCCTTTGATTGATAAAGGAGGGGGG
GAAGGGGTTGAAAGTTGATAAGTATAGTTTATGAATTTGAGACACAAGAAAAAGGTAATGCT
A 
>orf19.6689 
ACTTTACTGATTGATAAACAAAATATGGAAAAAGCTTTAACTATGGATATGTTGGCTACTGA
TTTAGCTGATTATTTAGTTAGAAAAGGAGTTCCATTTAGAGAAACTCATCATATATCTGGTGA
ATGTGTTAGAAAAGCTGAAGAAGAAAAATTATCTGGAATTGATCAATTATCTTTTGAACAAT
TTCAACAAATTGATTCTCGTTTTGAAAAAGACGTTATGGAAACTTTTGATTTTGAAGCTAGTG
TGGAAAGAAGAGATGCTATTGGTGGTACTGCTAAAAGTGCCGTTTTAAAACAATTAGAAAAT
TTAAAATCAATTTTAAGTTAATTTATAAATAGTCATATAATAATCACAGTATTGTTTAACTTA
CATAAAATATAATCAATTAACACAGAGATACCTTGTACTCCAATACTAGTGTTATAATGTTTA
TAACAGCAGCTTTCAAGAATAAGGAACTAAATAAAAGCTTCTTCCATCACAACACACAACAC 
>orf19.6480,orf19.6479 
TTAATCGGATTGGATTGGATTGAATCGGATTGGTATGAATTGGTCAGAAAAAGAGAGAAAGA
AAGAAAAAAAGAATTTTTTTTTTCCTTGGTGGGTGGGTGGTGTCTTGTTTTGGATCAACAACA
ACAAGCAATTTCATTATATACAACACGTATTCAAAATAACACGTATTCATTATATATATATAT
ATATATATATAGTCAACTACTAAAGATAAGAAAGATATTAACAAGATAAAAAAGGAATAAG
ATAGAAAGAACTATATAGGATATATAGATATACTAACACGCTTTTATTGTGTTATTTGTAAAG
CAGATTTTTAATGCAGGGATTGGGGTAGATGAAACAATTTCATATTACACACCAATTAAACT
CTTGAAGAAGGGAGTTGTTTCAAATGAGCAACTTTAATAAGCAATACGGGGCATTCACAAGT
AGATCGAAATAACACTTTCTTACCTTTAAACCATTAGTAATAGTAATAGTAGTAGTAGTAGTA
G 
>orf19.1043 
TTATTCTAATTCTAATTCTAATTTTTCTAGTTCTGGGAAATTAGTGGAAGATGTATCAAAATT
ACAAAATAAAATTGTGTTTTTATTTTTAGAAGGGACTTTATCAAATAATAAATCTATTTTACC
ATTTATTAAATTGAATTCTAAATATTCATTTGATGATTTTAATATTAAATCATTAGTTGTGAAA
TTAATACCAAATTATTTTACATTACCAATTCCTCATGTTAGTAAATTACAATATTTTTTCGAAC
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TTTTAACAAATTTATCTCAAAAACTGGTTCGTTATAAAATGTATAAATTTGATGAATTTGATA
TTGCCAAGATTAGAAATTCATTTGAATTGAATTCTTTAACTTCAATGAGTCAAGATTTGAATA
TTGATTCCAAGAATAAATTTATAGACTATTATTTTGATCATAGTATAAAGAAGAATTAAAAAT
GTTGTATATATAAATAAATATATATATATATATATGTATTATATGAAGCTACCCTTT 
>orf19.155 
ATCATATAATTGTTAATAATTTCGAATATTAAAAGAAAAAAGGGGAAACTGAGTTATATATC
ACAATTGTTGATTGTATCTGATTTAATGTCAAAATCTATAGATTATATCAATAGGAAATGGGG
TCTGCAGATAGATAAATAAATAAATAAGCAATTAAGTTAATGAATAAATGATTGAAAACCCA
AACTTATAATCAAAAAAAAAAAGCCAATATAGTAAATTTATTATAATCTGTGATAATTGATG
GAATAATGGGAATTTGATATATTTATGGAGGAGTAAATAAACCTCTTAATAATAGAAGATAA
GTATATAAATTAATATTAAATCAATTGAAATAAAACTAGTTGTGATTTATAATTAAGAACTA
GTAGTAGTAGTAGTAGTGGTGGTGATGGAGGTGATGAAGGTGGTGGTGATATGGGTGAGTTA
GTTAGTTAATTAGTTTGCTTATTTGTTTCAAGTTGAAAGAGAAAGAGAAAGAAGGAAAAAAT
TTT 
>orf19.4640 
AATTATAGAACATTCCCTATGGATGGAGGAATTGATAAAAAGACAAAAGAAGTTGTCGAAG
ATCAAACAAGTGGTATAGGTGTAGTTTTATTATAATTAGAGTGAAACTTTTATATATATATAT
ATATATATAATATAAAGCATTCCATGTTTTGGTTATGATTGCTAGTATAAGTATAAGTATAAG
CATAAGTATAAGTATAAGTATAAGTATAAGTAGAGTGGTTGTTGTTCATTTATTGATCATCTC
TGTCTTCACTTAAATTCTTTTTGTCAATCTTTTGGTAAAGAATTTTTTTTTTTTTTTGTTTTTTTG
TTTTTCAATCTCATCCCATTTTTTTTTTATTTTTTTTTGAAAAATAATTTCTATAATTCAAACCT
ACTCCCTTATTCCCTTCAATAATAGTAATAAATAAATAAATAGAAATAATGATTTCTTCAAGT
ACTTGGGTTCCAAGGGGTTTTGCTGCAGAATTCCCAGAGAAATATGAATTAGATGA 
>orf19.5454 
AACCCTTCCCATTCAGTTCTACCGGGCTCGTTCAAGTGGACATGTGCATCAACTAGCCCAGGC
ATAATCACTGCTGGCGTAACATTTCTATAGTCTATAGGAAAAACATTATAGCGTGCCAAAAT
CGGATCATTGGGCGGTAAAACCCTATCAACAATCTCTAAAATCGTGCCTGACTCTACCGAAA
AAATGATGGTGGCTGGTAAAAGTGTGTCATTAACCAACACTCTAGTCGATGATAATGCTCGT
GACATGGTTGCCTGATAAGAGAAAGAAAACTACTAAGGTCGACGAAATTTTTACAATATATA
TATTTTTTGAGATAAACTTTTTTTTCTCTTTGTGTAACGATTCGGTTTTGGCCGAAACACTCAT
CGGGATGCGAGGCCCACTAGTATGTGATCAATTGTTTACCCGATTTAGAATTGGCTACCCCAT
CTTTATACAACTCATGCAATTCCTTGCTACCATCAAATCTCGTCTCGGTCGATTTCGCATCT 
>orf19.915 
TTCATTTAATCCAATAAATGATGATGCTGATGATGTATGATTATTATTATTATTATTAATAAT
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AATTAAATCGGTACTTTTATTGAAAAAATATCTTTTGGAAGATTCATTTAATGCAAGGAAAAC
TAATGGATTAATTTCTAATTTATTGATTTGAATATTTATCAAATGATAATCAATTGGATAATT
AGTATTATGTAAATGTCCATGCATGCTCCCATCTAATAATCTTGCCGAAACATTAATTTGTTT
ATTTTGTAATAATCTTGTAATAATTGTCGACGTTTTTGTTTTCATTGATAATATTATTAAATCA
CCAATATTTTCAAAATTTAATATATGAGGTGATATTAATCCTTGTGAATTTTTACATTTATCAA
TAAATTCAAAACAATCTTGGAAAAATGGGATTTGATCATCTTCATGTCCATCAAACTTATCAT
ATTCATCATCTATATTATTCCCACAATTCATATCAAAATATTCATTATCATTACCCT 
>orf19.1587:orf19.1588 
CCAACCTAGAAGAGGGGTGATGCTATGTCTTTTATCAAGAAAGTTATGTATCGAAGTAGGAT
TAGGCATGGTTTAAAAAATGTTGACTTTCCAAAATAAAAAATTAACACAATCAACAAATCCA
CCTTTTTCTTTGCTTTGGGTTCTTGATATAATTTATATACCTCCTCAAAATCGGGTTTGTTTGC
AAAAGGGCCGCGACAATGGCACTGGGATCGCGAACAATTTTCATGGCTATCTATTGATTTAA
AATTTGATCTGACTCCGGCCATTTGCGAAATGTAAGGGCGCGTGCGACCTTACTTAGCAACA
GCAAACTAAGCCGGGTACCCGAATCGTTTTGTTTTATTAGAATTTATGGCACATGTATTCTAT
CAAATCATTCATGACGTCAGTAGCAAACTTCTATTACAGACCACAATAGCTTTTATGGGAAA
CTAAGACAATCACGTGGACATGTACTAACAACTAAGGAAAGTTAATTATGGTGACTCGTATC
T 
>orf19.1078 
AAATTTCAAATATTTAAAAGAAGAAGAAGAAGGAGGAGGAAGAGAAGGAGAGACAATCAT
TTTTTATTGTTGTTGTTGTTGTTGTTGTTTGTTGTTGATTAATAATATTATTAGTTAGGATGGA
GAGAGAGAGAGAGAGAGAGAGTCATATAAGACCAATGGAAAGTCTGGAGAAACGGAACTTT
TCCTTTTTTTCTTTCTTTCTTTCTTTCTTTTTGGTAGCTCTTT 
TGATTGCTTCAAAAATTCTCTCTCTCTCTCTCTTCTCCCCCCTCCCCGCCACCACGACTACTAC
TACTACTACTATTACTACTATTACTGCCCACTACCACCACCACCACCACTACCACTTGTTATC
AATTTTTTGTTCGACAAAAACTTTTTTTTTTCAGGTTTTTTTTTATCGTCGGAGATAACCGGAA
TCACGTGGAGAAGGAGTTGGCCTTCCGAAATGAGTAATATTACGCGGCTCTCACATACAAGA
ACTATCAATAGTTACTACA 
>orf19.1078(2ndprobe) 
TACTACTATTACTGCCCACTACCACCACCACCACCACTACCACTTGTTATCAATTTTTTGTTCG
ACAAAAACTTTTTTTTTTCAGGTTTTTTTTTATCGTCGGAGATAACCGGAATCACGTGGAGAA
GGAGTTGGCCTTCCGAAATGAGTAATATTACGCGGCTCTCACATACAAGAACTATCAATAGT
TACTACAATCTTTGATTAATTTTTTCGATAGCCGTTATTTTGGCAATCAACCTTAACTCTCTTT
AGATTAGCATTTTTGATTAGTTGTTCAGTTTGGCCTAAATATTTTTATGTGGTCTTTTTCTTTTT
TGACTCTGAAAAAATTATGGGGACAGCACAATAATACTGGCTTAGCAATGTCTTGATAATTG
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CTAATTAGTCTCGCGACAGGTTAA 
ATAATACGTTGAAAAGCACTTATAACTTCTGAATGATAAACTCCTTTATTACTATCAGTTGGA
GTACAAGTGTTATAGTTTTGGTTGTATATTTTG 
>orf19.1681 
GATGATTTGACTAGATTACCAGATGTGTTATTCAGTTACGTCAAACAATGGAGACATCCATTA
ATTGCTCAAAAGGGGGCTCCAGGTAAGAAAGAATTAGAAAGATTAAGAGACGTCCAACATT
TCACTCCATAGATGATATGATTATTTATAGTTTAAGTGTAAAGAGTTTATTTTTAAAAAGAAT
ATATTCAGTAAACTAATAGTTAAAAAAAGGGAATAAAAGTAGAACAATGCAGCAATGTTTTT
GAGGCTGAAATATAAATTCTGGAGATCTCCGAAGTTTAGACAACACCAAAAAAAAAAAGGA
AAGGAACTATATAAAGGCAGAAAGATAATCTCCATTCTACCAGTCTTAGTTTTTTTAAAGGT
GAAGAATATTTTTTGTACATCTAGTTAATATGGCATTACCAACAATCGAATCGTTCAAAAGAC
TATCATCAAAAGATAAAAGACAAGTGCTTGATCATTTATTTGAGCCATGCAATACATTATCC
AAT 
>orf19.6470,orf19.6472 
GATCTTAATTGCTATAGTTTCTTTACTGAGCACTGCCATGAAAAAGCTTTTTCTAACCAAAAG
GTTATGTTAATTTTGTGGAGAAGAGATTTTGATATTGTATTATAAGCTCTACGTCATTGAAAC
ATGTCACACATCACTAACTCTTGTAAACTTGTAAATTTTCGTCAATTCTTGAAATTACAACTC
TATTCTTCTAGTTGGATCAACCAATTGTCTAATTGACAGGAATTGTCGTCAAGTTGACGTGGT
TTTAGACCTAACTTTATTAGGTGGAGTAAAATTGAAATGGTGCGCCGGATATTACCGAGAAG
CCACACCCTCCCTCCCTCCAGTCTCTACAACCAAGATAAGACGAACAGCCAAAAAAACAAAA
AAATATCGATGCTATTTACCAACCCTCTTTCTTCAATTATCTATACTCCTCGATGTCATTTAAA
GAAGGTTCCAAGTTCCCAGCAGGTGTTGAATTCTCCTATATTCCAATTCAATTGGATGAT 
>orf19.2003 
ATCAGGTGGATTTATGGTTAAACTATGTGTGGCCAATTCTACGAGATATCTTCATGCGGCATC
CGCCGAAAGTTTATACAACAACAATAAGAAAAATATAAATACCTCATGCCAAATTATTATGT
GGGGCTAAAATTAGTGTTTATGTATTCTTGAGCAATTGATTGGTTATTGATTAAACTAGATTT
AGTAAATATGATCTTACTTCCAAACAACGGCAATCAATGCCTTTTTTTTTCGTAATTCAATTT
ATTTTATTGTTGGGAATGAAGATATTATACATACATACATCCTCAATAATTATGTCATTTCTA
CACAATTATAACGACTCTTTGGCTAAATAATCCCTACATTTGACTAATGCAGAAATCGGCTAT
ATCAAATCATTATCTGTAATAGAACTAATAAGTAATTTTAAAAATATTTGCAGTTAATAATCG
TAAATATTTCAAGAAGATCTTGATTCAACATTGGTTAAAAAAATTTAAAGGACGTTTCTT 
>orf19.6259 
CTGGTGAAAATGTAACTTGTTTCAATTCAGCCATGCTAAATGTTTGGTTTTTGGAGTTTGGAG
ATTGTTTGTATTTTAATGTTTGATGCTCATCACCAAAACGCATTAAACAGGTTGGAAAAAAAA
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AATCGAGACCATAAATGTCATCCGGGTAAATAAATTATTTGTACTGTATATAAAAAGTCACG
CTTAACTCACGTGCGTCGGAACTTTCCGGAAAAGTGTTCCCTAATTTGAAAGTTTATTAAGCA
ATGGTTGATTCCATTTTCGTTTATTTTTGGGGCCAAAATATTTACCAATTTTTACAAGAAAAA
AAAGTGCTTAAGGATTTAATCAAAATCATATGGGACAAATTGAATTTCTTGTTAATGCCGGA
ATCAATTTTACAAAAATCACATGATGGTCAAACCAATACACTCATTTTATTAATACAATAATA
TTATTTAATGATTGTAGTTTGCTTTCAATGGTTGGCCAAAGTATACTTGGTTTTCAGGCCA 
>orf19.7473 
TGTTGTTATTCTCATAGTAGTAGTCAGAGTCCTCACTAATGAAACTATTCATTACCAACCACT
AAAATTCTTTTGCTCTCTCTCTATTTTTGCATTCAATGTTGAGAATTAAATTGAATTTGAACCT
GTTTGAATGATCTGGTTTTTTTAATAAAGTGTGTAAATGTGAGTGAACAAGAAATCCGAAAA
TTCGCTCAACGCCGAAAAAAAAGCTTTAAAAAAATCAAAGTTATCTACGGAAAATAACGCA
AACACTCACCCGTAAATTACCCCCACCTACAACAACCAATATTAATTCACAAAATAAATATT
TTCAGTTTATTATTGCTTATATATACAATCAAATTGTCTGGTTTATTAAGTAATAGAGATTGTT
AAGGTAAAATTGAATTAAAGTACAACCAACAATATAACCAGATTGCAAATGTAGAACGATA
TATTAAAGCGTCGGAGTACAACAATCATTTCAAAGTTAATTGATTGGTTCATCTTTGGTATTT 
>orf19.2114 
GTCGGCTTTGGTGTACGATTCATCAAATTTACCTCTCAACAAAACCTGGACATTAGCTTCAAG
AACATCTTGCACAGTTGGGTTTGATGGATCTTTTTTGACCTTTAAAAATTTGACATTACCTTTA
CCGTAGGTTGAGGAGTATAATTCGGATTGCATGATTAGTTGTTGATTGAGAGAAAACTAGAA
AAAAAGGAAGAGGAATAAACCAGTCTATTTATACTTTTTTGTCCATATCTATTGGTTTGCTTT
AATTTCGGAGATCTCCACAGAAAGCCGCACACACGTCTACTTCAAGTAATCTCTGATAACAA
AAAAAAAAAAAAATCGGGGTGCCTATGCGGAGGACCGCAAACATATATTAACACTATTTAA
TCATTTTTCTTATCAGTATCAGCTGATTCTTCAACATTGCTTTCATCTTCGGCAAATCGTAAGC
TTTTTACTTTCTTGGTGGTTGTAGCGTCCTGAACACTTACCCCAGTTGCTTTAACATTTTC 
>orf19.3038 
ATTAGAAGAAACGTAAAATATATTGTTTCATTTCATGTGTGTATAATGTACTAGAGAAACTTC
ATAGAAAATGTATGAAGAATAAATTGCAAGTCCATTGGAGTAAGGATAATATCTGAGAAACT
TATAGGGATCAAATTTATTGTCAAAATGGTATCTTTATACTCTTATTCTTTGGTTGAATAGGTC
TTCAGTATAGTTTTATAGATATGATACTGTGTGTTTTCTTTTTGTCATATATCTTTACAACTAT
AATCTAGGTCTATGTGGTTCGCCTATATTCTCACCTGAGGCATCCACATACTTACATTCATCC
CCCAGCAGCTTTTTGCCTTGTCAACAAAAGAACTTTACGGGCAAAAGCGGATTCTGGTGGTG
ATCATATTTTTATTTTTGGTTCTTCGTTTTTGGTTTTTCTCAGCCGTCGAGGAAATTAGTTCTG
GAGTTGCCGGGAATACATACGTGATTTAAGTTGTGGTTGGTGGTATGATCATTGCTGC 
>orf19.1727 
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TTCATATCAGTATAATTCTTGTGGTGTTGTTTATCTTTAATTCCTTTCAAAAAAATTTTTAGTT
CTCAAATTGGATAAAATTTTTAAAACTTGCATTAAATAAATACTTACGTATATTAATCATCCA
TCTATCAAAATACTTGCATATATATATATATATATAACCAACAACTAATTTCCCACCAGGATA
AATTTTTTTTTTTTTTATTTTCAGAAAGAAAACCCTTTCTTTCAAATTATCAACACTTACTTTAT
ACTGTTTTATTATAATTATCATTTATTAATTAATTATTATTTAATTTAATCTACTATTTATCTAG
AAGAGAGAGTTATTATTATTTCTTTCAACACATTTTCCTTTCCAAAGCAAAGCAAAATTTTGA
GTTCATATATACAAATTAAACATTATTACTTATCCTCATATTTATATTTATATTCCGTACTATG
GCTCCAAGAACACCAGCCGATAAGCTTGGTCATGCATCTACATTACAACTCCC 
>snR74 
AGGAATTAACAGTCCCTAAACAACAGTAGACCGTCGTGAAAAAATGTGGTATAATCATCATA
AACATAGAAAAAACCACTTAATTATGTCTCCTTAAAACCAAACATATATATATATATATATAT
ACGAAAAACAACTAGAATCGGTTTTTATTGGAAATCTTCAATATAAATCATCTTTTTCTATTT
TTTTTTTTAAAAAAAAAACAATTTAAAAAATCAGACAATATACTTTATATATCTTCATTAATT
CAGACATATGCTTGTCAAAAAAAATTGTGAGGATAATTTCATCATATTTTAAAAATTTTGTTT
TTTTTTTATTTCATTTCATTTCATTTCAAATAATGACTATTGAAGACCCACTAAAATCCTGATT
TATAAATCTATTGTCTTCCCCCTTTATTAATTTAGTTAGTATAACAATTTCAATTTGGAAAAAA
ATAAAACAACAATAAAATTGACTTAGATCAGAAATGCATGAATGGTAATTAAATAAAA 
>orf19.4889 
ATCGTGTGACTATAAAAATATAAAGGATGCCAAATAGTAGTAGTAAAATAGTAAATAGAATT
GCAAAACAAAAATGATTAAATAGCCCTTTATCAATAAATTTTTAAAGTTAGTTTCTTCTGGAA
CCCTACCCTCTTGGTGTTAATCTTTTAAGTTAATATTTATAGTTAATAAAGTAGAAGTGTCTAT
TTATTGATTGTTGTTGTTGTTGATTAAGAATATAAAGAAAAACAGAAAAGAAAAAAAGAAGG
TTTAAAAAAGTTAATTGTGAAGTAAAAGGGTTGAAAAATTTTTTTTTTTTCTGTTTCTCTCTTT
GAGATTCTTTGACATATTTATTATTATAACACTATGCTATACTAAAAACAGTACTACCAATTG
AATTAAATTAAATTAAATTAAATTAAATTATTAGACCAATTTCAATAAAGATAAGCAATTTA
AGAATAGATGGATAGAT 
AAATAAACAGTACTCCACTCTTTTCTCTTCAAAAAAGATAAAA 
>orf19.3699 
ATTCATAATAAACAATTACGTGAATCATATATAAATTGGTTAAATATTATGAAATTTATAAAT
TTAAAAATCATTCGAATAGGTGGATTGAAATTATCTAATATTGATTATTTAAATATATCAATT
CTGACATATATTACAAAAATAGAAACTGACACTAGTGGTAATAGTAATAATAGATCAAATAC
AATTGTTAAAGAATTAATACAATTAACAAATGAGAATTGTGATATTGATAACCATGATGATG
GCCACGATGATTATTGGATAACTTATAATATTCATGATTTGAAGATTTTCCAATTGGAAGATA
TAATGATTGGAATTCAATCATGGAGTTATATTTGGTTTAATATTTTCTTTGAATCATTTAAATC
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AAATGGTCATGGTCATGGTCATCACAATAATAATAAGGTTTTATTCAATTGGGATGATGATAT
AGATGGATTTAAAGGATTTAAACAAAAGGGAATAAAATTATTTAATGAAATAGAATTACA 
>orf19.4656 
ATTTACAAAAATTATTATTGATAATGGGAAATATTATCGAGAAATATTGATTTTATATTTAAA
ATTTATTAAAAAATTGATTAAATTGACGAAACACAAAGATTCACCACCATATAAAGTGCTTG
AATATATATTTCAAAATCTTGATAAAGATCATAATAGCAACGATATTTTGGATATTAAATATT
TACTTTTACAGCAGGGGAGAAGATATACTAAAGAAATGTTTATGGAATTATTGAAAAGTTTA
GTACATGGAGTCAATACTACTAATGTTCTTGAACAATTGAAAACTATTGCTATAGTTAATCAA
CAAATATTAAATGGAGAGTTAATAGTTAATAATAATGATGTCGTTGATGAATTATTAGTGAA
AAATTATTTTCATCCGTTAGAAAATTTATTAAATCAATTCATATCATTATTAGAAGATTCAAA
ACTACAAGATAATAATAATAATAATCATAATAATCCTAATTGGGAAATCAAAATTTTCCAAA 
>orf19.4195.1 
AAGATCATTGAGCTATATTTATCTTTGATTTTTGGGTAAACCTCTTGCTAAAAGAAATTGCCA
TGATCTTCCATATTTAATGTGTATTATCTTTTCCATACACCTCACAGAACTTCCAGTAATACAA
TAAGCAAACGAAAGAGTAAAATAATAGACTCACATATTTATTTATCACTCCAACGACCATAC
CACAATTAACTTAAATATGTCCACTCAAACGTTTATAAGTTCACGGCACTTTAATTCCGCTTG
CGTTATCACGGCATTTTCCGTCTATTCAATTCCGTCTTGTGCACTTACGGGCCAAAATTTTTTT
TAAGGTGATGCTTTTAGCAACTTAGTTAACATCGCAAAAAAGCTTGTAAAATTCTCTTTCAAT
TCTTCTTGCTTTCAACAGTCACTTCAAAGTACCAATCTTTACTTTGTTTATTGCATTTATTACG
ATTTTAACATGACGTTTGACGACAAAAAAGGTTTACAAATCGCTCTTGATCAAGCCA 
>orf19.3799 
AACATTGAGAAACTTGTGAGTACCTTAGATATTGATTGAGCAATAAAAGAGTATCTATGTAA
TATATATTACAATTGCTCTTGTAGAAGAAATTGATTGAAAATTGCTAAATCTGAGTTATACTT
TTTTTTTGTTTTTATTTTTGTACATTAAACTTAGCAAAGATAAAAGCAAGAATTCCCTATTCAA
GGCAATTTAAAAAAAAGAACAAAAGAACAAACCCAAAGCAAATATTTAAAACTAATAAAGT
GTATTTGATAAAAGGTAGGTGATCAATAATAGATCAATTCAATTGAAAACAGAATAAATATA
TAGAAATGTAAAGAATTAAAATTAAATAGTACCAAGACTCAGAGGTTATAACCCTTTAAAAT
GCATTTATTATCGTCTCACTATTTAGTTTATAAAGATTGATTGAAAAAAATTTTTTTTTTTCTG
ATTTGAAATTTTTCCGTCAAATTTAGCACGACTAAAAAAAGAAGCATTTATTATTATTCAAC 
>orf19.3469 
GTAGTAGTGAGAGAGAGAGTGTGTGTGTGTGACACAAAATACAACTGACGCGATCAATTTAA
CTTAATTAAGAAAAAGAAAAGTAAAAAGTAAAAAGGAGGAGGAGGAACAAAAGAATTTTTA
ATTAATTAAGTTAATTAAGTTAATTAGTGTAGTAGTAGTGTAATAGTTGTTGAAGCAAGTCAA
AAAAAAAAGAAGAAATTAACAACGATCTTCTCAACTTCATCTTCCCACTCTTTTCTTACTCCT
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TTCAAATTGTTGAAATTGCTTATATCTGTTTCTTTTTTTGAATTGCTATCACTTTACTATATATA
TATATATATATGTATATATAATATCTATCAGTTTTTTATATTACTTTCCAAAAAAGAAATAGTT
TTTTTTTTTTACAGGACATCTTTCAATTCACTACAGATAATTTTCACTCCCTAATCATCAACCA
GTATCCAATATGTCAGCAACGATAATTGATAATGGACAACCAAAGGCAAAGACTCCAC 
>orf19.5701 
AATCTCATGATTATACAAATTCAACTCATTATCGAGATTTACAAAATTCTTATATTATGGATA
CAATTAATTTCTTATGGAAAGAACGATTTTTAAAACAAGATGCAAATTTAACTAATATTAGTT
CAAATAAAGGATTTTTTTTACATCCTGATTTTGAAAATAAATTAAATTCATTACATACTTTTG
ATTGTTCTTATTATTTATCTTCTTCACCTTCAACTATTGGAGAATTTTTTTATAATCCAGCTTTT
TCATATATCGTGACAAAAATCATTTGGGATATTGAAGATAATCATAATGGTATTAATACTAG
ACATGAAGGTCCTATATCAAGAGAAAGTTTAATACGATTAAGAAATGATAGTGATAAAATTT
GGTTATCATTATCATTTGATGAATTGAAATTGTCAATACTTCAAAATTTGGAAATTAAAAAAT
TTAATGGTATTGCTGATTTATTATTTAATTCTTTGAAAAGTTTAGCTGATAAAAGAAGT 
>orf19.1422:orf19.1421 
ATCGGAATGTGAATTTTGATCAATTCTCTTGTCAGGTTCTAGATTTGGAAAATCTCCCATTTCT
TTAAAAAGTTTTGCCTTAATAAATATGAAAAATGATCAGATATACTGTTGAGCTTTAACACA
GTTAGTTTGAAAAAATGATTATACTGCTATTAAGTGTAACGCTGTTTGAATACGTCTTTCGAT
AGTGGCACTGGATTTATAATTTTTTTTTTTCTCTTACTAACTCTTCCTCAGTTTATATGACAAA
TAGTGTATCCGCAAATTGGGTGATTAGTTTCTTTTTTTTTTCCCTTTGTTTTGTTTTGGTTTTTT
TTTCCCCGAATTTTCACGTGATCAGTAAATAATGCGTGTACGTATTCCAGGTGATTACGTAAG
ATTTACCTTCGGTTATCTCCATTCTTATCACTAGAATTTTTCAGCATAAAAATAGACAACAAG
TAAGTACTTTTTATTCTTCATTAAACAATGGTATTGAAAACATTCAAAGTTGATGG 
>orf19.193 
TCAAAATATTCATCACAAACAATTCAAAAGGCGCAATCTAAATTTGAAAAGAATTTTGATAT
TAAATTCAATTGTAATTGAAGGTTAACTATATATATATAGATATATATACATACATACATACA
TAATTAGTCTTGTTCTTTTATCTTAATTTATAAATTATTTAATTGATTGAGATTTTCAATTAAT
GAATCAATTTCCGGAAAATCATTAATGAAGAATTGTGATTTTTCTTGAATTGATTTACCTCCT
CCACTATTATCAATTTCTTCTGATAAATAAAGCATTAAAAATTCAATAATTTTGAAATTCGAA
TTATTATTTAATTCTTCATCTTCATTATTGTTATTATTACTGTTAGTGTTAGTGTTGGTGTTGTT
TTGATCATTAATATTTTCAAATGAACTCAATTTAAAATGTTTAATTAATATACTACAACCATT
TAAATCTTCAAATATTCGATAATTATCATAATTCTTCAATAAAATATGAATTAAAGT 
>orf19.2827 
AAATTAAAGATCAACAATCAATTATTGAAGAATTAAAAATTCAAGATTCTTTAATGAAACGG
AAACTGGATGATTTAAAACAAACAATTTTTCAAATACAAAATGAATTTAATAGTCAAATTGA
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ATCATTAGATCAACAAATTAGAGAAACTAAATCAAATATTCAATCGGATATTTTACAATTGG
AAAGAAAATTACGTGATGTCAATTTGAATAAAAGTTTGATTCAAGAACAATTGATTGGTAAA
CGACAAAAAATTGATGAAGATGTCATTAATTTAACGTCATTTATATTGAAATTTAAAACTAAT
ATTCAAGAAAAATTGATTAATATTGCTGATATTGTTCAAGATCAATTGAAAAAAGAACAACA
ACAACAACAACAACAACAAGCATCACAACAGCTAGAGTGAAAAAAGAGTTTCATTAATGTT
CAGTTAAATCAAATAAATTCTTTAACTTAATCTTATTATCAATAATTCGTTTTCTAAACATGC
ACT 
>orf19.1707 
TCAATAGTCAATTTTCTGACAACTCTTTTCTTATCATCTAAAGCAGGTAATAAATCATTTAAT
AATTTTTGTTTATTAATAATATCATCAAATTTTTCAATTATTAATTTCAAATTCTTTAAACTTA
ATACTTTAATATCAATATTCGATTTTGATTTCCCTTTTGTTGTTGCGGATGTAATTAATTCAAT
TAAAATTGGGATTAATTCAGTAATATTCTTCTTAGTCAATAATGATGAATTTGTATTGATGGT
GGCGATGGTATCTTTTTCTTGATCAGTTTCCATCTCTTTCTATAATTCTCAATCTGTATCTATA
TCGTTTTCTTCTTCTTTTAAAATAATATTCAATATTATCAATGATGCCAATAAATTTGAATTTG
AATTAGCATCTATTGGAATTTTAATTAATGAATATAATGTAATTGGTAGAATTTCTGATAATT
GATTAATTAAAATATTATTATTACCATTAATTGATAAATTTTCAATAATCAATGA 
>orf19.3633 
TATGAAACAATTGAACAATGACACCAGAAGCTGGTGTTCCTAATGTGGTATCTAATATATGA
CAAGTAATTGGATCAACAGACATTATGGAAAAAAAAAAAGGATATGTATGTTTTCAAGGTGC
TATTATGTTAACTGGTGAATATATGGTTTGCCTTGTAGTTGGCTATAAAAATGATAATACTGA
AAGAAAGAATTGAAAGAAGTATTGCTGATATTTTTTTCTATATATATGGTGGATTCAATTTAG
TTTTATATAGTTTGATAAGATATTTCTCTCCCACCGCAGATAACCGAAGATCAAAATTGCTCT
CTCCGCAAAATCACCAATTACAAATAAACCCACACAAATGGTAATAAATATACTATATAAAT
AAATAAATAAATAAGGTAAACATAAAGGTTCTATAATAATTATCCTATATATTTCCATGATAT
GTTTTTTGTATCATATTTCCATAAACGATCTTGTTTTAAAACCATTGTCAAAATGTAATCAA 
>orf19.4231 
TTGACTTTTAATCGCTTCTAACCATATCAACACGTTTAAAACTTTTTTCTTTCTTTCTTTTTTTC
TTTCTTTTTTTTTTTTTAGTTTTTTAAATTCACTGGAGAATTATATAAATATCAAAGCAAATAA
CCTCTATTTCCAATTCTAGTTTCAACCAACCTTTTCCTTTTTCAATCTTTGAATATCATTATTGG
GATCTTGAATTTTTCAAATATTGCTTTTATTTTTTCATTGCATTTTTAACGATTTCACTTACTTT
TCTTTGTTTTTGTCACTTATTTCTTCTTAACTATTCAACAATAACAACAACAACAGTTCTTGAT
TCAAATTTATTCACTATATTTAAATACGATTTCACTATTCCTCTACTGTTGCTTGCTATTACGT
TATTAACATAATCTATTTATTTTTTCATTTGCTACGATCTACCACCAAAAAAAAAAATGTTAA
TCATCTCAGAATTCAATCCTCAATTAATGCATTCGGACGATTCCGAAGAC 
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>orf19.35 
TCTGCAAATTATGTTTAAAAATATTGATCAATTGAAAATTTGGAAATTAAAAGATGTTTTAAT
TGAAAAATATAAATTTAATAAAAATGATTATGAAGTTGATTTAATTTGTGATTTGATTTTAAA
ATGTTTAAAATATGATTTAAATGAAAGATACGATGCTAATTCTTTATTAAAACATCCTTGGTT
TGATAGTGATAACAATAGCACTATTAGTCCTGGATTGGAAGATAGATTGAAAAATTTACCAA
ATTGTCATGATGATTTACCGGGTTATACATGTGAATGTAAAATATAAAGAAACTACAAATTA
ATTAACAATTAAGATTATATAAATATATTACATACATACATATATATATATGTTTAGTTGTTT
TTTCTGGTTTACATATAGCACATATGAAAGAGATGTTTTGATTTATTAACAATAATGGGAATA
ATAATGGGGTATTAATGCTCTCTACACATTAAAAAATACTATCAGTACCAATTCAATCCAC 
>orf19.4152 
TAGTGCTCACCAAAGACAAAAAAAAAAAAGATTAAAGTGATGAGAACAAGAGAATCACAAC
TGAAAAAATTTTTTTTTTTTTTTTTTGCTTCCTTTGCCTTTCTCTCTCTCTCTCTCTGGCCACTCT
TTCTATATCTTAATTAAACAGAATAGAACATAAAAAAAAAGAAACTGCTATTAATATAATAA
CACACACAATATACACTAAGAATTTATATGTTCCTGTATATTAGTTGCCTATCTTAACACATT
ACCAGAGATTAACAATTACCCTGCTAGATTGTAAGTGTTTCAAAGATATGATTTGATATACA
ACAACATTATCAACAACAACAACAACCTACATGTTATAGATAGAGAAATAGAAATTAGAAG
AGAGTGAAGAAAAAAGATTACATATTCACTTGGGTTGGGTGATTACTTATCAAGTTTAGTGC
ATGAGCTACTTTTCTTTTTTTTTGACTTCTTTCTTCTGTCGTTGGTTGATGTGTCTTCTCAAG 
>orf19.1041 
TTGGTTGTAACTTTTTTTTTTTTCCACCATCTGGTTTGTTTGTTTGTTTGTTGATGTTGTGTTGG
ACTGCTAAATTTTTTTTTTTTTTCCTTACTTGTACGAACAGAGGATGGATGGATACTTTTGAGG
ATGGATGGATACTTTTGAGAAAGCATAACTTTGAGTTATTATATCTATTTAGATAATCCGGAT
AAACTCTACAGTATGTATTTGTTTTCTAATTTGATTATAGTAATCGTATACTAAATAATAAAT
ACTTATAAAGACAAATAAATTTAGAATAATTCCATTTTGGTTTTTTTTTTTGTTTTTTTTTTTTG
GGTTCTGGTATAGTTTTATATATATATATATATATATTCATTGACCTGAAATCATTTTGTTTTT
AAGCAGCAAAAGACAAAGAGAAACCTAATTTATGAACTGGTTCAGCCAATTTCAAGGCATC
AAAGGAAGCACCCAAACCTAATTTAACCCCTGGTCTTAATTCTTGAGTGTAAGAC 
>orf19.7038 
AAACAATTATCAATTAATCAAATTGATTTATTAGATAAACGTATAAAAGATCAAGAAATTAA
ATTTAAAAAAATTAGTGAAGAAAATCCTGATATCAAAGGTGGTGAATTAATTAAATTAAGAC
AATCAATTATAAATGATAAACAAGAAATTTTTCAACAATTAAATAAAGATTGGTTAATTAAA
CAATGTTGTTTACAAGAATTTATTATTTTCCAAGAAACTCAATTTTTAATTACGGAACTTTGG
GTTGAATGGTGTAAAGATCGTTTGAAATGTCAAGAGAAATTAGTTGGTTTATATGATAATTTA
AATCAAGAAATTATTCATGATATGCCTCTAGAGAGATGATCCCCTTGAGAGATGATCCTAGA
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AAGATAAAGCTTTTAGTAGTAATTCCTTCAACTTCTATATCTATACATACTATTTTAATTTACT
GTCATTTCATTTCATTTCATTTCATTTCATTCTCCCATTTATTAATTAATTCATGATATGAT 
>orf19.6570 
CCTTTATCTTTTTAGTAAATAAATTACTGTAACTTTAAACTCGTTGATAATGATAAATTAAAA
CAAATCGTAATAGCTTTGTTCCCAAATAGGAAAACTGATAAACTATTGTTGTTTTTGTTGCTG
CTGAAAGAATGTTCCGATTTTCCAATGGAACGGCAAAACTTCTCACTTTCGGGGAAATGCAT
CGGAAGTTTGTCACCTATTATTAAAAAGCAGGCACGGCATCAAATAGATAAAGAAATTAAAT
ATTATTAGGAACAAGATAAAAGAAGTCAACTTAGTATACATTTAAAATGTAACGGTATTGTA
CTGTTCTTAGTGTAATTGTGATGATTTGTAGGACCATTTTAGTTTGTGAAACTTTTTAGGTCTC
ATCTCAATTTGTTTACTAAATGAACCGTTTGAGTAAACGATACAAAAGTAGGTTTCATTATAT
TCTGTTCTGTTTAATTAATCAATATATGAAAAATTAGACAATTTTTTTGACTTCTATAATT 
>orf19.1080 
TGCTAATTAGTCTCGCGACAGGTTAAATAATACGTTGAAAAGCACTTATAACTTCTGAATGAT
AAACTCCTTTATTACTATCAGTTGGAGTACAAGTGTTATAGTTTTGGTTGTATATTTTGTGTGG
GTCTAAGACAATTTCTATTTTAACACTATTTTTTCGCAATTATTTGCAGTTAAATATTGTATGA
TAAGTATTTTCATAAAACTGTTAACCACCACAAATATTATCAATCTACTATTTAATCAGCTTC
TGGAAACAACAAGCAAAAACATTGTTAACCTATTTTTTACTTGCCCCCCCCCCCAAATATTAT
AGTATAACATAATATTTAATAAACAAGATGTATAAATGTGTAACCACTTTAATTTTTCTTTAA
TCCTAAACTTTCTTTAAATGAATTGGCTTTTGTGATTCATTAATACTTAACATAACTATTTTGT
TATGAAAAAGGTGTCCAAAAACATTATTGGAAACTGAACAACAACCACCTTAACCT 
>orf19.6972 
AAGCGGGGGGGATGAATAATAATCTTAAAAAGAAAGAACAAATGAATCAATGAATCAATGA
ATGAATGAATAATTAAACGGGAATTCTTAAGGGGAATTGAAATCAAATGTGAAATTGGTGGT
AATCAGAATTTTGTTTTAGTTGATAATTTTAAAGAAAAGAAAAAAAAAAAAGGGGAGGTAGT
GTTAATTGGTTCAAAACAAATTTAAACTTTATAAATTCTGAAAACGCGTCTGCGTCTGAAATT
ATAACAAAACATTTTTTTTTAAAGTGTAGCATCACGTGACTCGGAATTATAACTTTATTATTA
CTACTTAACTGATACATTTTTATATTCATTACAAATCAAACCATTCGAAAACTATAAACATCT
TCTTAATTGCCCAATCTAAATATGATATTCAAGTAATCTTGAATTATTTTCTTTCAATAACACT
TCATCTTCATTCCAAACAATTTTAATAATATCATAAAATTCTTTAGCATAAAACAAGGAAAT 
>orf19.5026 
TGCTTTTTTTTTTCTCTTCTTGTTCTCTGTTCTCTTATGTTGAGTGTATGTTAATAAATATTTAA
TGTATGCTTTGTGTGTATGGATGAGTGTTTCTTTCTTTTTTTTTTCCTCTTTATTTTATAGCTTC
TTTAGTTAAGACACTTTTTTCAAAAGATTTCCACCAAAAAGGGTAAATAATAATAGGAATAA
TAACAAAATTATTAGAACTTATGGGACGATGTAATATAAAGTACGGTCGTTGAATCAATTAT
 96 
 
AATAATATGTGTAGATGTGTGAAGATGTGTGAGTTTATGATGATTTATAAAATGAAGTAACT
TTTTTATTGAGAAATTTGTTTGTAATATGGGGTAAAGGAAGTCAAATATAGTTGGAAATTAGT
AGTTATTCTTCTTCTTCTCGAGTTCCCAAATTAAATATTATAAGGATATTGATTGTCGTTTAGA
TATTATACAAAGACACCTTAATGAAATTGAAATCAACCTTCAAAACAAAAGGAAAAG 
>orf19.1716 
TAATTTTGAAGATTATAATGATGTTCTTGAAGCGTAAAACATTTGACCCCCCTGTCATGATTT
CTAGAAGGACCACCTTTGATTGTAAATAGTAATAATTACCACCCTTATTTAATTATTTATTTA
ACTTATTTATTTATTTATTATACATATATACAAATCTAATAAAGTGAAAATCTCCCCCTTCAC
ATTTATAATTGGCCAGTTTTTTTCAAATAAGCATTCCAACCAGCATCTCTATACCTTTTACCTT
CAATATCTGGATCTCTTCCTTTACCAAACAATCCTCTACCAACAATGATAATATCAGTTCCAG
TGCTAACAACTTCATCAACAGTTCTATATTGTTGTCCTAATCCATCACCTTTATCATCTAATCC
AACTCCAGGTGTCATAATAAGCCAATCAAATCCTTCTTCTTGTCCACCCATATCACGTTGGGC
AATAAATCCAATAACAAATTCCTTATCGGATTTAGCAATTTCAACAGTTTTTTGAGA 
>orf19.1716(2ndprobe) 
TCTTAGTGTTGACTGTCATATCTTTTGTTTGCTATTTCTATTTCTATTTCTTTCTTCAACTGTAA
AAGGGGCGATATATAAACCAGTGTGTATGGGGTTGTTGCTCAGGAATTGATCAATGTTTAAA
AGAATGGTTGAAATCATCATTGAAGAACAAAAAAAAAGATTTTTTCTTTCATTATGTTATCTG
TATAATATGCAGGAAATAAGATTGCAAAAAAATAGCCGTTTTTTTGGATACTATCAAACAAG
AGGAATGACTAATACAGAATTAGTGTTACGAATCAATGGCACTACAGCAACTTTCAACAAAA
TAATCTACGTTCAAAATATAATATATACTATTAAATAAAATCAAATAATAAAATAATTTTAA
AGAAAGTAGTACCAGCTCTTTTTTTTGTTTCCGTTTATACCATCCAAATCAATTCCTATTAGTA
CTTTGTAATTACTCTCAGTTCAAACTGTTTAAATAATTCATAAGTTTTTTTTGAAATGGA 
 
